Skip to Main Content
CWRU Links


2011 Member Publications

This is a list of publications authored by Cancer Center members. Cancer Center members are highlighted in BOLD text. 

Publications are listed in alphabetical order by first author. 

Abbas R, Kombu RS, Ibarra RA, Goyal KK, Brunengraber H, Sanabria JR. The dynamics of glutathione species and ophthalmate concentrations in plasma from the VX2 rabbit model of secondary liver tumors. HPB Surg 2011:709052, 2011. PMCID: PMC3042630


Abraham J, Nelon LD, Kubicek CB, Kilcoyne A, Hampton ST, Zarzabal LA, Giles FJ, Michalek JE, Rubin BP, Keller C. Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model. Sarcoma 2011:130484, 2011. PMCID: PMC3087964


Abraham J, Prajapati SI, Nishijo K, Schaffer BS, Taniguchi E, Kilcoyne A, McCleish AT, Nelon LD, Giles FG, Efstratiadis A, Legallo RD, Nowak BM, Rubin BP, Malempati S, Keller C. Evasion mechanisms to igf1r inhibition in rhabdomyosarcoma. Mol Cancer Ther 10:697-707, 2011.


Adams GN, Larusch GA, Stavrou E, Zhou Y, Nieman MT, Jacobs GH, Cui Y, Lu Y, Jain MK, Mahdi F, Shariat-Madar Z, Okada Y, D'Alecy LG, Schmaier AH. Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis. Blood 117:3929-3937, 2011. PMCID: PMC3083303


Adler DS, Lazarus H, Nair R, Goldberg JL, Greco NJ, Lassar T, Laughlin MJ, Das H, Pompili VJ. Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy. Front Biosci (Elite Ed) 3:506-514, 2011.


Advani AS, Gibson S, Douglas E, Diacovo J, Elson PKalaycio MCopelan ESekeres MSobecks R, Sungren S, Lagoo A, Rizzieri D, Hsi E. Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukemia (ALL). Br J Haematol 153:504-507, 2011.


Advani AS. Blinatumomab: a novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol 9:776-777, 2011.


Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MATiu RVKalaycio M, O'Keefe CL, Maciejewski JP. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood 117:6876-6884, 2011. PMCID: PMC3128479


Afable MG, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani AKalaycio MTiu RV, O'Keefe CL, Maciejewski JP. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica 96:1269-1275, 2011. PMCID: PMC3166096


Agaiby S, Iyer K, Honda K, Mostow EN. Giant pilomatrix carcinoma in an immunosuppressed patient. J Am Acad Dermatol 65:e50-e51, 2011.


Aghajanian C, Sill MW, Darcy KM, Greer B, McMeekin DS, Rose PG, Rotmensch J, Barnes MN, Hanjani P, Leslie KK. Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. J Clin Oncol 29:2259-2265, 2011. PMCID: PMC3107744


Agrawal D, Maimone SS, Wong RC, Isenberg G, Faulx A, Chak A. Prevalence and clinical significance of pancreatic cysts associated with cysts in other organs. Dig Liver Dis 43:797-801, 2011.


Ahluwalia MS, Patel M, Peereboom DM. Role of tyrosine kinase inhibitors in the management of high-grade gliomas. Expert Rev Anticancer Ther 11:1739-1748, 2011.


Ahluwalia MS, Patton C, Stevens G, Tekautz T, Angelov L, Vogelbaum MAWeil RJChao SElson PSuh JHBarnett GHPeereboom DM. Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas. J Neurooncol 102:317-321, 2011.


Ahluwalia MS, Wen PY. Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions. Expert Rev Anticancer Ther 11:653-656, 2011. PMID: 21554035


Ahluwalia MS. 2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies. Expert Rev Anticancer Ther 11:161-163, 2011. PMID: 21342033


Ahluwalia MS. American Society of Clinical Oncology 2011 CNS tumors update. Expert Rev Anticancer Ther 11:1495-1497, 2011. PMID: 21999122


Ahmed T, Rieder F, Fiocchi C, Achkar JP. Pathogenesis of postoperative recurrence in Crohn's disease. Gut 60:553-562, 2011.


Ahuja JS, Börner GV. Analysis of meiotic recombination intermediates by two-dimensional gel electrophoresis. Methods Mol Biol 745:99-116, 2011.


Albert JM, Nelson S. Generalized causal mediation analysis. Biometrics 67:1028-1038, 2011. PMCID: PMC3139764 Albiges L, Salem M, Rini B, Escudier B. Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma. Hematol Oncol Clin North Am 25:813-833, 2011.


Aldabagh B, Patel RR, Honda K. Leukemia cutis in association with Grover's disease. Am J Dermatopathol 33:e41-e43, 2011.


Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA 306:1205-1214, 2011.


Al-Harbi S, Hill BT, Mazumder S, Singh K, Devecchio J, Choudhary G, Rybicki LA, Kalaycio MMaciejewski JPHoughton JAAlmasan A. An antiapoptotic Bcl-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood 118:3579-3590, 2011. PMCID: PMC3186334


Ali S, Yu C, Palmer FL, Ganly I, Shaha A, Shah JP, Kattan MW, Patel SG. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia. Arch Otolaryngol Head Neck Surg 137:1154-1160, 2011.


Allen KL, Hamik A, Jain MK, McCrae KR. Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors. Blood 117:6383-6391, 2011. PMCID: PMC3122956


Allington TM, Schiemann WP. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells. Cells Tissues Organs 193(1-2):98-113, 2011. PMCID: PMC3245834


Amengual J, Lobo GP, Golczak M, Li HN, Klimova T, Hoppel CL, Wyss A, Palczewski K, von Lintig J. A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J 25:948-959, 2011. PMCID: PMC3042841


Anand S, Wilson C, Hasan T, Maytin EV. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Cancer Res 71:6040-6050, 2011.


Anderson BR, Muramatsu H, Jha BK, Silverman RH, Weissman D, Karikó K. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res 39:9329-9338, 2011.


Anderson JM, McNally AK. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin Immunopathol 33:221-233, 2011.


Andres Ibarra R, Abbas R, Kombu RS, Zhang GF, Jacobs G, Lee ZBrunengraber H, Sanabria JR. Disturbances in the glutathione/ophthalmate redox buffer system in the woodchuck model of hepatitis virus-induced hepatocellular carcinoma. HPB Surg 2011:789323, 2011. PMCID: PMC3175733


Angulo S, Morales A, Danese S, Llacuna L, Masamunt MC, Pultz N, Cifone MG, De Simone C, Delgado S, Vila J, Panés J, Donskey C, Fernández-Checa JC, Fiocchi C, Sans M. Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase. PLoS One 6:e16953, 2011. PMCID: PMC3052310


Argiris A, Karamouzis MV, Gooding WE, Branstetter BF, Zhong S, Raez LE, Savvides P, Romkes M. Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer. J Clin Oncol 29:1140-1145, 2011. PMCID: PMC3083869


Arif A, Jia J, Moodt RA, Dicorleto PE, Fox PL. Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control. Proc Natl Acad Sci U S A 108:1415-1420, 2011. PMCID: PMC3029695


Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MM, Pavletic SZ. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood 117:6714-6720, 2011. PMCID: PMC3123030


Ashing-Giwa KT, Lim JW. Examining emotional outcomes among a multiethnic cohort of breast cancer survivors. Oncol Nurs Forum 38:279-288, 2011.


Ashing-Giwa KT, Lim JW. Health-related quality of life outcomes among cervical cancer survivors: examining ethnic and linguistic differences. Cancer Epidemiol 35:194-201, 2011.


Askar M, Sobecks R, Morishima Y, Kawase T, Nowacki A, Makishima H, Maciejewski J. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Biol Blood Marrow Transplant 17:1409-1415, 2011.


Astsaturov IA, Meropol NJ, Alpaugh RK, Burtness BA, Cheng JD, McLaughlin S, Rogatko A, Xu Z, Watson JC, Weiner LM, Cohen SJ. Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma. Am J Clin Oncol 34:70-75, 2011. PMCID: PMC3030655


Atkins GB, Jain MK, Hamik A. Endothelial differentiation: molecular mechanisms of specification and heterogeneity. Arterioscler Thromb Vasc Biol 31:1476-1484, 2011. PMCID: PMC3134408


Augoff K, Das M, Bialkowska K, McCue B, Plow EFSossey-Alaoui K. miR-31 is a broad regulator of β1-integrin expression and function in cancer cells. Mol Cancer Res 9:1500-1508, 2011. PMCID: PMC3219821


Auletta JJ, Zale EA, Welter JF, Solchaga LA. Fibroblast growth factor-2 enhances expansion of human bone marrow-derived mesenchymal stromal cells without diminishing their immunosuppressive potential. Stem Cells Int 2011:235176, 2011. PMCID: PMC3062108


Avalos BR, Lazaryan A, Copelan EA. Can G-CSF cause leukemia in hematopoietic stem cell donors? Biol Blood Marrow Transplant 17:1739-1746, 2011.


Averbook BJ. Mitotic rate and sentinel lymph node tumor burden topography: integration into melanoma staging and stratification use in clinical trials. J Clin Oncol 29:2137-2141, 2011.


Avva J, Weis MC, Soebiyanto RP, Jacobberger JWSreenath SN. CytoSys: a tool for extracting cell-cycle-related expression dynamics from static data. Methods Mol Biol 717:171-193, 2011.

Babsky AM, Ju S, George B, Bennett S, Huang M, Jayaram HN, McLennan G, Bansal N. Predicting response to benzamide riboside chemotherapy in hepatocellular carcinoma using apparent diffusion coefficient of water. Anticancer Res 31:2045-2051, 2011.


Bahuleyan B, Omodon M, Robinson S, Cohen AR. Frameless stereotactic endoscope-assisted transoccipital hippocampal depth electrode placement: cadaveric demonstration of a new approach. Childs Nerv Syst 27:1317-1320, 2011.


Bailey DE Jr, Wallace M, Latini DM, Hegarty J, Carroll PR, Klein EA, Albertsen PC. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res 24:193-199, 2011. PMCID: PMC3070758


Balanis N, Yoshigi M, Wendt MK, Schiemann WPCarlin CR. β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells. Mol Biol Cell 22:4288-4301, 2011. PMCID: PMC3216655


Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC; Regimen-Related Toxicity Writing Committee, CIBMTR. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant 17:737-744, 2011. PMCID: PMC3035737


Barnholtz-Sloan JChance MR. Frontiers of oncology: biobanking resources for the 21st century. J Clin Bioinforma 1:13, 2011. PMCID: PMC3164606


Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck TR. Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 20:1146-1155, 2011. PMCID: PMC3111844


Barykova YA, Logunov DY, Shmarov MM, Vinarov AZ, Fiev DN, Vinarova NA, Rakovskaya IV, Baker PS, Shyshynova I, Stephenson AJKlein EA, Naroditsky BS, Gintsburg AL, Gudkov AV. Association of Mycoplasma hominis infection with prostate cancer. Oncotarget 2:289-297, 2011. PMCID: PMC3248169


Basappa NS, Elson P, Golshayan AR, Wood L, Garcia JADreicer RRini BI. The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib. Cancer 117:1183-1189, 2011.


Basu A, Alder H, Khiyami A, Leahy P, Croce CM, Haldar S. MicroRNA-375 and microRNA-221: potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer. Genes Cancer 2:108-119, 2011. PMCID: PMC3111247


Beach JR, Hussey GS, Miller TE, Chaudhury A, Patel P, Monslow J, Zheng Q, Keri RAReizes O, Bresnick AR, Howe PH, Egelhoff TT. Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 108:17991-17996, 2011. PMCID: PMC3207690


Beatty K, Winkelman C, Bokar JAMazanec P. Advances in oncology care: targeted therapies. AACN Adv Crit Care 22:323-334, 2011.


Bebek G, Koyutürk M, Chance MR, Price ND. Integrative -omics for translational science - session introduction. Pac Symp Biocomput 1-3, 2011. PMID: 21121027


Bebek G, Orloff M, Eng C. Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma. J Clin Bioinforma 1:21, 2011. PMCID: PMC3170587


Beck RC. Production of cytotoxic, KIR-negative NK cells from CD34+ cord blood cells with the use of Notch signaling. Transfusion 51(Suppl 4):145S-152S, 2011.


Bego MG, Keyes LR, Maciejewski J, St Jeor SC. Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo. Arch Virol 156:1847-1851, 2011.


Behbakht K, Sill MW, Darcy KM, Rubin SC, Mannel RS, Waggoner S, Schilder RJ, Cai KQ, Godwin AK, Alpaugh RK. Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 123:19-26, 2011.


Behshad R, Garcia-Zuazaga J, Bordeaux JS. Systemic treatment of locally-advanced, nonmetastatic cutaneous squamous cell carcinoma: a review of the literature. Br J Dermatol 165:1169-1177, 2011.


Belinson JL, Wu R, Belinson SE, Qu X, Yang B, Du H, Wu R, Wang C, Zhang L, Zhou Y, Liu Y, Pretorius RG. A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II study. Am J Clin Pathol 135:790-795, 2011.


Bencsath KP, Reu F, Dietz J, Hsi ED, Heresi GA. Idiopathic systemic capillary leak syndrome preceding diagnosis of infiltrating lobular carcinoma of the breast with quiescence during neoadjuvant chemotherapy. Mayo Clin Proc 86:260-261, 2011. PMCID: PMC3046949


Bennett KL, Campbell R, Ganapathi S, Zhou M, Rini BGanapathi R, Neumann HP, Eng C. Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma. Genes Chromosomes Cancer 50:654-661, 2011. PMCID: PMC3110575


Berencsi K, Rani P, Zhang T, Gross L, Mastrengelo M, Meropol NJ, Herlyn D, Somasundaram R. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2. J Transl Med 9:33, 2011. PMCID: PMC3076246


Beriwal S, Macklis RM, Basu S. Preface: radiation therapy planning with PET. PET Clin 6:xi, 2011.


Berry DC, Jin H, Majumdar A, Noy N. Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc Natl Acad Sci U S A 108:4340-4345, 2011. PMCID: PMC3060239


Betapudi V, Gokulrangan G, Chance MREgelhoff TT. A proteomic study of myosin II motor proteins during tumor cell migration. J Mol Biol 407:673-686, 2011. PMCID: PMC3072708


Blake V, Joffe S, Kodish E. Harmonization of ethics policies in pediatric research. J Law Med Ethics 39:70-78, 2011.


Blanke CD, Goldberg RM, Grothey A, Mooney M, Roach N, Saltz LB, Welch JJ, Wood WA, Meropol NJ; on behalf of the NCI GI Steering Committee Colon Cancer Task Force. KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice. Oncologist 16:1061-1068, 2011.


Blum AE, Hatter A, Honda K, Lu K. An unusual presentation of Buschke-Ollendorff syndrome. J Am Acad Dermatol 65:e25-e26, 2011.


Bodo J, Hsi ED. Phosphoproteins and the dawn of functional phenotyping. Pathobiology 78:115-121, 2011


Bodo J, Hsi ED. Selection and validation of antibodies for signal transduction immunohistochemistry. Methods Mol Biol 717:45-53, 2011.


Bodo J, Sedlak J, Maciejewski JPAlmasan AHsi ED. HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. Apoptosis 16:914-923, 2011.


Bonda DJ, Lee HG, Camins A, Pallàs M, Casadesus G, Smith MAZhu X. The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol 10:275-279, 2011. PMCID: PMC3163839


Borden EC, Jacobs B, Hollovary E, Rybicki L, Elson P, Olencki T, Triozzi P. Gene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trial. J Interferon Cytokine Res 31:433-440, 2011. PMCID: PMC3083725


Borden EC, Williams BR. Interferon-stimulated genes and their protein products: what and how? J Interferon Cytokine Res 31:1-4, 2011.


Bosch X, Lozano F, Cervera R, Ramos-Casals M, Min B. Basophils, IgE, and autoantibody-mediated kidney disease. J Immunol 186:6083-6090, 2011.


Bose A, Taylor JL, Alber S, Watkins SC, Garcia JARini BI, Ko JS, Cohen PA, Finke JH, Storkus WJ. Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination. Int J Cancer 129:2158-2170, 2011. PMCID: PMC3110980


Brady AK, Fu AZ, Earl M, Kalaycio MAdvani ASaunthararajah YSobecks RCopelan ESekeres MA. Race and intensity of post-remission therapy in acute myeloid leukemia. Leuk Res 35:346-350, 2011.


Brennan CW, Prince-Paul M, Wiencek CA. Providing a "good death" for oncology patients during the final hours of life in the intensive care unit. AACN Adv Crit Care 22:379-396, 2011.


Brognard J, Zhang YW, Puto LA, Hunter T. Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase. Cancer Res 71:3152-3161, 2011. PMCID: PMC3078168


Buchner DA, Yazbek SN, Solinas P, Burrage LC, Morgan MG, Hoppel CLNadeau JH. Increased mitochondrial oxidative phosphorylation in the liver is associated with obesity and insulin resistance. Obesity (Silver Spring) 19:917-924, 2011; Erratum 19:2286, 2011.


Bulek K, Liu C, Swaidani S, Wang L, Page RC, Gulen MF, Herjan T, Abbadi A, Qian W, Sun D, Lauer M, Hascall V, Misra SChance M, Aronica M,Hamilton TLi X. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol 12:844-852, 2011.


Burden-Gulley SM, Qutaish MQ, Sullivant KE, Lu H, Wang J, Craig SE, Basilion JPWilson DLBrady-Kalnay SM. Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detail. Cancer Res 71:5932-5940, 2011. PMCID: PMC3173511


Burdick MJ, Neumann D, Pohlman B, Reddy CA, Tendulkar RD, Macklis R. External beam radiotherapy followed by (90)y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma. Int J Radiat Oncol Biol Phys 79:1124-1130, 2011.

Calabrese C, Faiman B, Martin D, Reu F, Calabrese LH. Type 1 cryoglobulinemia: response to thalidomide and lenalidomide. J Clin Rheumatol 17:145-147, 2011.


Caloglu M, Ciezki JP, Reddy CA, Angermeier K, Ulchaker J, Chehade N, Altman A, Magi-Galluzzi CKlein EA. PSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up. Int J Radiat Oncol Biol Phys 80:735-741, 2011.


Campbell SC, Lee B. Management of small renal masses: donating kidneys to your local pathologist is not advised. Emerg Cancer Ther 2:57-72, 2011.


Campbell SC, Palese MA. Laparoscopic cryoablation for a 3 cm nonhilar renal tumor. J Urol 185:14-16, 2011.


Campbell SC. Editorial comment [Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma]. Urology 77:1397-1399, 2011.


Caplan AI, Correa D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res 29:1795-1803, 2011.


Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell 9:11-15, 2011. PMCID: PMC3144500


Carrino DA, Calabro A, Darr AB, Dours-Zimmermann MT, Sandy JD, Zimmermann DR, Sorrell JM, Hascall VC, Caplan AI. Age-related differences in human skin proteoglycans. Glycobiology 21:257-268, 2011. PMCID: PMC3010768


Carroll JK, Antognoli E, Flocke SA. Evaluation of physical activity counseling in primary care using direct observation of the 5As. Ann Fam Med 9:416-422, 2011. PMCID: PMC3185466


Cata JP, Klein EA, Hoeltge GA, Dalton JE, Mascha E, O'Hara J, Russell A, Kurz A, Ben-Elihayhu S, Sessler DI. Blood storage duration and biochemical recurrence of cancer after radical prostatectomy. Mayo Clin Proc 86:120-127, 2011. PMCID: PMC3031436


Chakrabarti A, Jha BK, Silverman RH. New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res 31:49-57, 2011. PMCID: PMC3021357


Chamberlain MC, Barnholtz-Sloan JS. Medical treatment of recurrent meningiomas. Expert Rev Neurother 11:1425-1432, 2011.


Chan DV, Somani AK, Young AB, Massari JV, Ohtola J, Sugiyama H, Garaczi E, Babineau D, Cooper KD , McCormick TS. Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32). BMC Biochem 12:27, 2011. PMCID: PMC3127830


Chan DV, Summers P, Tuttle M, Cooper KDCooper BKoon HHonda K. Anaplastic lymphoma kinase expression in a recurrent primary cutaneous anaplastic large cell lymphoma with eventual systemic involvement. J Am Acad Dermatol 65:671-673, 2011. PMCID: PMC3156415


Chan ER, Hester J, Kalady M, Xiao H, Li X, Serre D. A novel method for determining microflora composition using dynamic phylogenetic analysis of 16S ribosomal RNA deep sequencing data. Genomics 98:253-259, 2011. PMCID: PMC3168955


Chan ES, Patel AR, Larchian WA, Heston WD. In vivo targeted contrast enhanced micro-ultrasound to measure intratumor perfusion and vascular endothelial growth factor receptor 2 expression in a mouse orthotopic bladder cancer model. J Urol 185:2359-2365, 2011.


Chao ST, Angermeier K, Klein EA, Reddy CA, Ulchaker JC, Stephenson A , Campbell SCiezki JP. Prophylactic urethral stenting with Memokath(R) 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II study. J Contemp Brachytherapy 3:18-22, 2011.


Chao ST, Kobayashi T, Benzel E, Reddy CA, Stevens GH, Prayson RA, Kalfas I, Schlenk R, Krishnaney A, Steinmetz MP, Bingaman W, Hahn J, Suh JH. The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas. J Neurosurg Spine 14:59-64, 2011.


Chattopadhyay S, Yamashita M, Zhang Y, Sen GC. The IRF-3/Bax mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication. J Virol 85:3708-3716, 2011. PMCID: PMC3126131


Chaudhuri BN, Gupta S, Urban VS, Chance MR, D'Mello R, Smith L, Lyons K, Gee J. A combined global and local approach to elucidate spatial organization of the Mycobacterial ParB-parS partition assembly. Biochemistry 50:1799-1807, 2011. PMCID: PMC3081668


Chaudhury A, Hussey GS, Howe PH. 3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end. RNA Biol 8:595-599, 2011.


Chavarria D, Ramos-Serrano A, Hirao I, Berdis AJ. Exploring the roles of nucleobase desolvation and shape complementarity during the misreplication of O(6)-methylguanine. J Mol Biol 412:325-339, 2011. PMCID: PMC3167027


Chen K, Li W, Major J, Rahaman SO, Febbraio MSilverstein RL. Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. Blood 117:5744-5750, 2011. PMCID: PMC3110031


Chen X, Thorburn DR, Wong LJ, Vladutiu GD, Haas RH, Le T, Hoppel C, Sedensky M, Morgan P, Hahn SH. Quality improvement of mitochondrial respiratory chain complex enzyme assays using Caenorhabditis elegans. Genet Med 13:794-799, 2011.


Chen Y, Chen CF, Chiang HC, Pena M, Polci R, Wei RL, Edwards RA, Hansel DE, Chen PL, Riley DJ. Mutation of NIMA-related kinase 1 (NEK1) leads to chromosome instability. Mol Cancer 10:5, 2011. PMCID: PMC3025975


Chen Y, Wang W, Zhou Y, Shields R, Chanda SK, Elston RC, Li J. In silico gene prioritization by integrating multiple data sources. PLoS One 6:e21137, 2011. PMCID: PMC3123338


Cheng L, Roth LM, Zhang S, Wang M, Morton MJ, Zheng W, Abdul Karim FW, Montironi R, Lopez-Beltran A. KIT gene mutation and amplification in dysgerminoma of the ovary. Cancer 117:2096-2103, 2011.


Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JNBao S. Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun 406:643-648, 2011. PMCID: PMC3065536


Cheng L, Wu Q, Huang Z, Guryanova OA, Huang Q, Shou W, Rich JNBao S. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J 30:800-813, 2011. PMCID: PMC3049209


Cheng L, Zhang S, Alexander R, Maclennan GT, Hodges KB, Harrison BT, Lopez-Beltran A, Montironi R. Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation. Am J Surg Pathol 35:e34-e46, 2011.


Cheng L, Zhang S, Alexander R, Yao Y, Maclennan GT, Pan CX, Huang J, Wang M, Montironi R, Lopez-Beltran A. The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. Future Oncol 7:519-541, 2011.


Cheng L, Zhang S, Maclennan GT, Williamson SR, Lopez-Beltran A, Montironi R. Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol 42:455-481, 2011.


Cheng Y, Meyers JD, Agnes RS, Doane TL, Kenney MEBroome AMBurda CBasilion JP. Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? Small 7:2301-2306, 2011.


Cheng Y, Meyers JD, Broome AMKenney MEBasilion JPBurda C. Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. J Am Chem Soc 133:2583-2591, 2011. PMCID: PMC3056176


Cheon H, Yang J, Stark GR. The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J Interferon Cytokine Res 31:33-40, 2011. PMCID: PMC3021352


Cheriyath V, Kuhns MA, Kalaycio ME, Borden EC. Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma. Br J Cancer 104:957-967, 2011. PMCID: PMC3065279


Cheriyath V, Leaman DW, Borden EC. Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer. J Interferon Cytokine Res 31:173-181, 2011.


Cherkassky L, Lanning M, Lalli PN, Czerr J, Siegel H, Danziger-Isakov L, Srinivas T, Valujskikh A, Shoskes DA, Baldwin W, Fairchild RL, Poggio ED. Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker. Am J Transplant 11:1388-1396, 2011. PMCID: PMC3226763


Ching CB, Amin MB, Tubbs RR, Elson P, Platt E, Dreicer R, Fergany A, Hansel DE. HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Mod Pathol 24:1111-1119, 2011.


Cho KR, Huang Y, Yu S, Yin S, Plomp M, Qiu SR, Lakshminarayanan R, Moradian-Oldak J, Sy MS, De Yoreo JJ. A multistage pathway for human prion protein aggregation in vitro: from multimeric seeds to β-oligomers and nonfibrillar structures. J Am Chem Soc 133:8586-8593, 2011.


Choi I, Wells BJ, Yu C, Kattan MW. An empirical approach to model selection through validation for censored survival data. J Biomed Inform 44:595-606, 2011.


Choueiri TK, Xie W, Kollmannsberger C, North S, Knox JJ, Lampard JG, McDermott DF, Rini BI, Heng DY. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. J Urol 185:60-66, 2011.


Chowdhury SA, Nibbe RK, Chance MRKoyutürk M. Subnetwork state functions define dysregulated subnetworks in cancer. J Comput Biol 18:263-281, 2011. PMCID: PMC3123978


Chu FM, Picus J, Fracasso PM, Dreicer R, Lang Z, Foster B. A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human αv integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer. Invest New Drugs 29:674-679, 2011.


Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant 17:1018-1024, 2011. PMCID: PMC3114180


Chuang CH, Doane TL, Lo SS, Scholes GD, Burda C. Measuring electron and hole transfer in core/shell nanoheterostructures. ACS Nano 5:6016-6024, 2011.


Chueh SC, Flechner S, Goldfarb D, Sankari BR, Campbell S. Re: Tollefson et al.: Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient (Urology 2010;75:1373-1377). Urology 77:254-255, 2011.


Cipriano R, Jackson MW. Delineating oncogene/tumor suppressor interactions in human mammary epithelial cells. Cell Cycle 10:2612-2613, 2011.


Cipriano R, Kan CE, Graham J, Danielpour D, Stampfer M, Jackson MW. TGF-β signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci U S A 108:8668-8673, 2011. PMCID: PMC3102347


Clemente MJ, Wlodarski MW, Makishima H, Viny AD, Bretschneider I, Shaik M, Bejanyan N, Lichtin AE, Hsi ED, Paquette RL, Loughran TP Jr,Maciejewski JP. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood 118:4384-4393, 2011. PMCID: PMC3204910


Cohen DJ, Clark EC, Lawson PJ, Casucci BA, Flocke SA . Identifying teachable moments for health behavior counseling in primary care. Patient Educ Couns 85:e8-e15, 2011.


Cohn DE, Kim KH, Resnick KE, O'Malley DM, Straughn JM Jr. At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysis. J Clin Oncol 29:1247-1251, 2011.


Coleman RL, Brady WE, McMeekin DS, Rose PG, Soper JT, Lentz SS, Hoffman JS, Shahin MS. A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study. Gynecol Oncol 122:111-115, 2011. PMCID: PMC3104117


Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, Monterey MD, Galloway MP, Sloan AE, Mathupala SP. Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia 13:620-632, 2011. PMCID: PMC3132848


Cotta CV, Coleman JF, Li S, Hsi ED. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. Histopathology 59:1194-1203, 2011.


Cousino M, Hazen R, Yamokoski A, Miller V, Zyzanski S, Drotar D, Kodish E; on behalf of the Multi-site Intervention Study to Improve Consent Research Team. Parent participation and physician-parent communication during informed consent in child leukemia. Pediatrics 128:e1544-e1551, 2011.


Crabtree BF, Nutting PA, Miller WL, McDaniel RR, Stange KC, Jaén CR, Stewart E. Primary care practice transformation is hard work: insights from a 15-year developmental program of research. Med Care 49:S28-S35, 2011. PMCID: PMC3043156


Craig SE, Brady-Kalnay SM. Cancer cells cut homophilic cell adhesion molecules and run. Cancer Res 71:303-309, 2011.


Craig SE, Brady-Kalnay SM. Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools. Anticancer Agents Med Chem 11:133-140, 2011.


Cucullo L, Hossain M, Puvenna V, Marchi N, Janigro D. The role of shear stress in blood-brain barrier endothelial physiology. BMC Neurosci 12:40, 2011. PMCID: PMC3103473


Cucullo L, Marchi N, Hossain M, Janigro D. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow Metab 31:767-777, 2011. PMCID: PMC3049530


Cui TX, Lin G, Lapensee CR, Calinescu AA, Rathore M, Streeter C, Piwien-Pilipuk G, Lanning N, Jin H, Carter-Su C, Qin ZS, Schwartz J. C/EBPβ mediates growth hormone-regulated expression of multiple target genes. Mol Endocrinol 25:681-693, 2011. PMCID: PMC3063086


Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG. Lrp5 functions in bone to regulate bone mass. Nat Med 17:684-691, 2011. PMCID: PMC3113461


Cummings LC, Cooper GS. Colorectal cancer screening: update for 2011. Semin Oncol 38:483-489, 2011.


Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD. Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 103:1452-1460, 2011. PMCID: PMC3186782

Dabir S, Kluge A, Aziz MA, Houghton JADowlati A. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors. Cancer Biol Ther 12:139-151, 2011. PMCID: PMC3154286


Daly BJ. Caring for the critically ill patient with cancer. AACN Adv Crit Care 22:321-322, 2011.


Daneshmand S, Stephenson AJ, Sheinfeld J, Jewett MA. The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation. Urol Oncol 29:842-847, 2011.


Dao H Jr, Barr PM, Honda K . Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox. J Am Acad Dermatol 64:e123-e125, 2011.


Darian E, Guvench O, Yu B, Qu CK, Mackerell AD Jr. Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase. Proteins 79:1573-1588, 2011. PMCID: PMC3076527


Das M, Ithychanda SS, Qin JPlow EF. Migfilin and filamin as regulators of integrin activation in endothelial cells and neutrophils. PLoS One 6:e26355, 2011. PMCID: PMC3197140


Das R, Plow EF. Phosphatidylserine as an anchor for plasminogen and its plasminogen receptor, Histone H2B, to the macrophage surface. J Thromb Haemost 9:339-349, 2011.


Daud S, Hamrahian AH, Weil RJ, Hamaty M, Prayson RA, Olansky L. Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration? Pituitary 14:414-417, 2011.


Davis MP, Kirkova J, Lagman R, Walsh D, Karafa M. Intolerance to mirtazapine in advanced cancer. J Pain Symptom Manage 42:e4-e7, 2011.


Davis MP. Fentanyl for breakthrough pain: a systematic review. Expert Rev Neurother 11:1197-1216, 2011.


Davis MP. Opioid tolerance and hyperalgesia: basic mechanisms and management in review. Prog Palliat Care 19:73-86, 2011.


Davis MP. Reversal of cancer cachexia and wasting prolongs survival. J Pain Symptom Manage 41:656-657, 2011.


Dazard JE, Zhang K, Sha J, Yasin O, Cai L, Nguyen C, Ghosh M, Bongorno J, Harter ML. The dynamics of E1A in regulating networks and canonical pathways in quiescent cells. BMC Res Notes 4:160, 2011. PMCID: PMC3125344


Debernardo R, Starks D, Barker N, Armstrong A, Kunos CA. Robotic surgery in gynecologic oncology. Obstet Gynecol Int 2011:139867, 2011. PMCID: PMC3236394


Delahunt B, Sika-Paotonu D, Bethwaite PB, William JT, Magi-Galluzzi C, Zhou M, Samaratunga H, Srigley JR. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol 35:1134-1139, 2011.


Demerjian S, Campbell SC . Editorial comment [Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors]. Urology 77:786, 2011.


Demko CA. Lasting change: sustaining improvements in oral health care. J Public Health Dent 71(Suppl 1):S97-S98, 2011.


Demshar R, Vanek R, Mazanec P. Oncologic emergencies: new decade, new perspectives. AACN Adv Crit Care 22:337-348, 2011.


Devarajan J, Siyam AM, Alexopoulos AV, Weil R, Farag E. Non-convulsive status epilepticus in the postanesthesia care unit following meningioma excision. Can J Anaesth 58:68-73, 2011.


Devine SM, Carter S, Soiffer RJ, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Stadtmauer EA, Alyea EP 3rd, Keever-Taylor CA, O'Reilly RJ. Low risk of chronic graft-versus-host disease and relapse associated with T-cell depleted peripheral blood stem cell transplantation for acute myeloid leukemia in first remission: results of the Blood and Marrow Transplant Clinical Trials Network protocol 0303. Biol Blood Marrow Transplant 17:1343-1351, 2011. PMCID: PMC3150599


Dhingra RR, Jacono FJ, Fishman M, Loparo KA, Rybak IA, Dick TE. Vagal-dependent nonlinear variability in the respiratory pattern of anesthetized, spontaneously breathing rats. J Appl Physiol 111:272-284, 2011. PMCID: PMC3137531


Distelhorst CW, Bootman MD. Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca(2+) signaling and disease. Cell Calcium 50:234-241, 2011. PMCID: PMC3172391


Do JS, Visperas A, Dong C, Baldwin WM 3rd, Min B. Cutting edge: generation of colitogenic Th17 CD4 T cells is enhanced by IL-17+ γδ T cells. J Immunol 186:4546-4550, 2011. PMCID: PMC3200541


Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, Ransohoff RM, Popovich PG. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci 31:9910-9922, 2011. PMCID: PMC3139517


Dowlati A, Kundranda M, Manda S, Patrick L, Fu P. Temporal evolution of patient characteristics enrolled on phase I trials. Invest New Drugs 29:312-315, 2011.


Downs-Holmes C, Silverman P. Breast cancer: overview & updates. Nurse Pract 36:20-26, 2011.


Downs-Kelly E, Rubin BP. Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies. Patholog Res Int 2011:708596, 2011. PMCID: PMC3090201


Dreicer R, Bajorin DF, McLeod DG, Petrylak DP, Moul JW. New data, new paradigms for treating prostate cancer patients-VI: novel hormonal therapy approaches. Urology 78(5 Suppl):S494-S498, 2011.


Dreicer RGarcia J, Hussain M, Rini B, Vogelzang N, Srinivas S, Somer B, Zhao YD, Kania M, Raghavan D. Oral enzastaurin in prostate cancer: a two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease. Invest New Drugs 29:1441-1448, 2011.


Dreicer R, Gleave M, Kibel AS, Thrasher JB, Moul JW. Targeting the androgen receptor-theory and practice. Urology 78(5 Suppl):S482-S484, 2011.


Dreicer R, Moul JW. New data, new paradigms for treating patients with prostate cancer. Conclusion. Urology 78(5 Suppl):S499, 2011.


Du H, Yi J, Wu R, Belinson SE, Qu X, Yang B, Wang C, Yi X, Belinson JL. A new PCR-based mass spectrometry system for high-risk HPV, part II: clinical trial. Am J Clin Pathol 136:920-923, 2011.


Du J, Zhang J, Su Y, Liu M, Ospina JK, Yang S, Zhu AJ. In vivo RNAi screen reveals neddylation genes as novel regulators of Hedgehog signaling. PLoS One 6:e24168, 2011. PMCID: PMC3169580


Dubyak GR. Charge of the mito brigade. Focus on "Changes in mitochondrial surface charge mediate recruitment of signaling molecules during apoptosis". Am J Physiol Cell Physiol 300:C11-C13, 2011. PMCID: PMC3023193


Duong HK, Bolwell BJ, Rybicki L, Koo A, Hsi ED, Figueroa P, Dean RPohlman BKalaycio M, Andresen S, Sobecks RCopelan E. Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield. J Clin Apher 26:111-115, 2011.

Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA. Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 103:1162-1178, 2011. PMCID: PMC3149042


Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EAStephenson AJ. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 185:869-875, 2011.


Egleston BL, Miller SM, Meropol NJ. The impact of misclassification due to survey response fatigue on estimation and identifiability of treatment effects. Stat Med 30:3560-3572, 2011.


Elbahesh H, Jha BK, Silverman RH, Scherbik SV, Brinton MA. The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells. Virology 409:262-270, 2011. PMCID: PMC3046042


Ellis RJ, Kaminsky DA, Zhou EH, Fu P, Chen WD, Brelin A, Faulhaber PF, Bodner D. Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (prostascint) in a cohort diagnosed with localized prostate cancer. Int J Radiat Oncol Biol Phys 81:29-34, 2011.


Elmunzer BJ, Sonnenday CJ, Taylor JR, Furlan JP, Schomisch SJ, Scheiman JM, Chak A, Marks JM, Ponsky JL. Endoscopic access to and exploration of the lesser sac in a human cadaver model: opportunity for transgastric endoscopic pancreatic surgery (with video). Surg Endosc 25:2725-2730, 2011.


Eng C. Something old, something new. Endocr Relat Cancer 18:E1, 2011.


Erokwu B, Flask C, Gulani V. High field diffusion tensor imaging in small animals and excised tissue. Methods Mol Biol 771:139-152, 2011.


Erten S, Bebek G, Koyutürk M. Vavien: an algorithm for prioritizing candidate disease genes based on topological similarity of proteins in interaction networks. J Comput Biol 18:1561-1574, 2011. PMCID: PMC3216100


Expert Panel on Radiation Oncology–Prostate, Frank SJ, Arterbery VE, Hsu IC, Abdel-Wahab M, Ciezki JP , Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. Brachytherapy 10:357-362, 2011.


Eyler CE, Wu Q, Yan K, Macswords JM, Chandler-Militello D, Misuraca KL, Lathia JD, Forrester MT, Lee J, Stamler JS, Goldman SA, Bredel M, McLendon RE, Sloan AEHjelmeland ABRich JN. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 146:53-66, 2011. PMCID: PMC3144745

Fader AN, Frasure HE, Gil KM, Berger NA, von Gruenigen VE. Quality of life in endometrial cancer survivors: what does obesity have to do with it? Obstet Gynecol Int 2011:308609, 2011. PMCID: PMC3205677


Fairman JW, Wijerathna SR, Ahmad MF, Xu H, Nakano R, Jha S, Prendergast J, Welin RM, Flodin S, Roos A, Nordlund P, Li Z, Walz T, Dealwis CG. Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization. Nat Struct Mol Biol 18:316-322, 2011. PMCID: PMC3101628


Falzarano SM, Zhou M, Carver P, Tsuzuki T, Simmerman K, He H, Magi-Galluzzi C. ERG gene rearrangement status in prostate cancer detected by immunohistochemistry. Virchows Arch 459:441-447, 2011.


Falzarano SM, Zhou M, Hernandez AV, Klein EA , Rubin MA, Magi-Galluzzi C. Single focus prostate cancer: pathological features and ERG fusion status. J Urol 185:489-494, 2011.


Fan W, Tang Z, Yin L, Morrison BH, Hafez-Khayyata S, Fu P, Huang H, Bagai R, Jiang S, Kresak AM, Howell S, Vasanji A, Flask CA, Halmos B, Koon HB,Ma PC. Met-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents. Cancer Res 71:4494-4505, 2011. PMCID: PMC3132557


Farag SS, Maharry K, Zhang MJ, Pérez WS, George SL, Mrózek K, Dipersio J, Bunjes DW, Marcucci G, Baer MR, Cairo M, Copelan E, Cutler CS, Isola L,Lazarus HM, Litzow MR, Marks DI, Ringdén O, Rizzieri DA, Soiffer R, Larson RA, Tallman MS, Bloomfield CD, Weisdorf DJ; on behalf of the Acute Leukemia Committee of the Center for International Blood and Marrow Transplant Research and Cancer and Leukemia Group B. Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant 17:1796-1803, 2011.


Fardini Y, Wang X, Témoin S, Nithianantham S, Lee D, Shoham M, Han YW. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol 82:1468-1480, 2011. PMCID: PMC3237733


Farha S, Asosingh K, Xu W, Sharp J, George D, Comhair S, Park M, Tang WH, Loyd JE, Theil K, Tubbs R, Hsi E, Lichtin A, Erzurum SC. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood 117:3485-3493, 2011. PMCID: PMC3072874


Farley J, Sill MW, Birrer M, Walker J, Schilder RJ, Thigpen JT, Coleman RL, Miller BE, Rose PG, Lankes HA. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study. Gynecol Oncol 121:303-308, 2011. PMCID: PMC3081894


Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, Macdonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489-495, 2011.


Feng T, Elston RC, Zhu X. Detecting rare and common variants for complex traits: sibpair and odds ratio weighted sum statistics (SPWSS, ORWSS). Genet Epidemiol 35:398-409, 2011. PMCID: PMC3114642


Feng W, Madajka M, Kerr BA, Mahabeleshwar GH, Whiteheart SW, Byzova TV. A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood 117:3893-3902, 2011. PMCID: PMC3083301


Feng X, Scheinberg P, Wu CO, Samsel L, Nunez O, Prince C, Ganetzky RD, McCoy JP Jr, Maciejewski JP, Young NS. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica 96:602-606, 2011. PMCID: PMC3069238


Fensterl V, Sen GC. The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31:71-78, 2011. PMCID: PMC3021354


Fernandez HF, Sun Z, Litzow MR, Luger SM, Paietta EM, Racevskis J, Dewald G, Ketterling RP, Rowe JM, Lazarus HM, Tallman MS. Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia but is not improved with gemtuzumab ozogamicin. Blood 117:5306-5313, 2011. PMCID: PMC3109705


Finke J, Ko J, Rini B, Rayman P, Ireland J, Cohen P. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. Int Immunopharmacol 11:856-861, 2011. PMCID: PMC3109226


Fiocchi C, Lund PK. Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol 300:G677-G683, 2011. PMCID: PMC3094134


Fiocchi C. Early and late inflammatory bowel disease: why and how are they different? Curr Opin Gastroenterol 27:317-320, 2011.


Fishovitz J, Li M, Frase H, Hudak J, Craig S, Ko K, Berdis AJ, Suzuki CK, Lee I. Active-site-directed chemical tools for profiling mitochondrial lon protease. ACS Chem Biol 6:781-788, 2011. PMCID: PMC3158820


Fitzpatrick JM, Bellmunt J, Dreicer R, Fleshner NE, Logothetis CJ, Moul JW, Tombal B, Zlotta A. Maximizing outcomes in genitourinary cancers across the treatment continuum. BJU Int 107(Suppl 2):1-12, 2011.


Flocke SA , Stange KC, Cooper GS, Wunderlich TL, Oja-Tebbe N, Divine G, Lafata JE. Patient-rated importance and receipt of information for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 20:2168-2173, 2011. PMCID: PMC3189279


Forrester MT, Eyler CE, Rich JN. Bacterial flavohemoglobin: a molecular tool to probe mammalian nitric oxide biology. Biotechniques 50:41-45, 2011. PMCID: PMC3096140


Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, …et al, Marincola FM, Gajewski TF, Wigginton JM, Disis ML. Defining the critical hurdles in cancer immunotherapy. J Transl Med 9:214, 2011.


Foy SP, Labhasetwar V. Oh the irony: iron as a cancer cause or cure? Biomaterials 32:9155-9158, 2011. PMCID: PMC3193037


Francis LE, Bowman KF, Kypriotakis G, Rose JH. Relationships and emotional wellbeing among African American and White advanced cancer caregivers. Patient Educ Couns 85:446-453, 2011. PMCID: PMC3134587


Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, et al…, Eng C, Neumann HP; International RET Exon 10 Consortium. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat 32:51-58, 2011.


Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA. Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys 80:751-757, 2011.


Frullano L, Wang C, Miller RHWang Y. A myelin-specific contrast agent for magnetic resonance imaging of myelination. J Am Chem Soc 133:1611-1613, 2011. PMCID: PMC3086979


Fu AS, Thatiparti TR, Saidel GMvon Recum HA. Experimental studies and modeling of drug release from a tunable affinity-based drug delivery platform. Ann Biomed Eng 39:2466-2475, 2011.


Fujioka H, Moghaddas S, Murdock DG, Lesnefsky EJ, Tandler B, Hoppel CL. Decreased cytochrome c oxidase subunit VIIa in aged rat heart mitochondria: immunocytochemistry. Anat Rec (Hoboken) 294:1825-1833, 2011.


Fukuda K, Knight JD, Piszczek G, Kothary R, Qin J. Biochemical, proteomic, structural, and thermodynamic characterizations of integrin-linked kinase (ILK): cross-validation of the pseudokinase. J Biol Chem 286:21886-21895, 2011. PMCID: PMC3122243


Fukuzawa N, Petro M, Baldwin WM 3rd, Gudkov AV, Fairchild RL. A TLR5 agonist inhibits acute renal ischemic failure. J Immunol 187:3831-3839, 2011. PMCID: PMC3178726


Funderburg NT, Jadlowsky JK, Lederman MM, Feng Z, Weinberg A, Sieg SF. The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signaling patterns in human monocytes. Immunology 134:151-160, 2011. PMCID: PMC3194223


Fyffe-Maricich SL, Karlo JC, Landreth GEMiller RH. The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci 31:843-850, 2011.

Gaddipati H, Fu PDowlati A. Phase I clinical trials in patients ≥80. J Geriatr Oncol 2:142-146, 2011. PMCID: PMC3097467


Gale RP, Lazarus HM. How helpful are meta-analyses in determining the best therapy of blood diseases? Acta Haematol 125:91-101, 2011.


Galsky MD, Hahn NM, Rosenberg J, Sonpavde G, Hutson T, Oh WK, Dreicer R, Vogelzang N, Sternberg C, Bajorin DF, Bellmunt J. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. Lancet Oncol 12:211-214, 2011.


Galsky MD, Hahn NM, Rosenberg J, Sonpavde G, Hutson T, Oh WK, Dreicer R, Vogelzang N, Sternberg CN, Bajorin DF, Bellmunt J. Treatment of patients with metastatic urothelial cancer "unfit" for cisplatin-based chemotherapy. J Clin Oncol 29:2432-2438, 2011.


Ganapathi RNBukowski RM. Predicting responses to sunitinib using single nucleotide polymorphisms: progress and recommendations for future trials. Genome Med 3:79, 2011.


Gao X, Huang L, Grosjean F, Esposito V, Wu J, Fu L, Hu H, Tan J, He C, Gray S, Jain MK, Zheng F, Mei C. Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15. Kidney Int 79:987-996, 2011.


Gao Y, Abreha M, Nelson KN, Baird H, Dudley DM, Abraha A, Arts EJ. Enrichment of intersubtype HIV-1 recombinants in a dual infection system using HIV-1 strain-specific siRNAs. Retrovirology 8:5, 2011. PMCID: PMC3025951


Garcia JADreicer R. Immunotherapy in castration-resistant prostate cancer: integrating sipuleucel-T into our current treatment paradigm. Oncology (Williston Park) 25:242-249, 2011.


Garcia JA, Hutson TE, Shepard DElson PDreicer R. Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial. Cancer 117:752-757, 2011.


Garcia JA, Mekhail T, Elson PTriozzi P, Nemec C, Dreicer RBukowski RMRini BI. Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial. BJU Int 107:562-570, 2011.


Garcia JA. Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists. Ther Adv Med Oncol 3:101-108, 2011. PMCID: PMC3126040


Gargesha M, Qutaish MQ, Roy D, Steyer GJ, Watanabe M, Wilson DL. Visualization of color anatomy and molecular fluorescence in whole-mouse cryo-imaging. Comput Med Imaging Graph 35:195-205, 2011. PMCID: PMC3049862


Gastman B. Reply: excising value at a marginal cost: rethinking the management of basal cell carcinoma. Plast Reconstr Surg 127:2137, 2011.


Gerken TA, Jamison O, Perrine CL, Collette JC, Moinova H, Ravi L, Markowitz SD, Shen W, Patel H, Tabak LA. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. J Biol Chem 286:14493-14507, 2011. PMCID: PMC3077648


Gettman MT, White WM, Aron M, Autorino R, Averch T, Box G, Cadeddu JA, Canes D, Cherullo E, Desai MM, Frank I, Gill IS, Gupta M, Haber GP, Humphreys MR, Irwin BH, Kaouk JH, Kavoussi LR, Landman J, Liatsikos EN, Lima E, Ponsky LE, …et al.; Endourological Society NOTES and LESS Working Group; European Society of Urotechnology NOTES and LESS Working Group. Where do we really stand with LESS and NOTES? Eur Urol 59:231-234, 2011.


Gholam PM, Lee Z. Quantitative measurement of liver function: the quest for the holy grail? J Nucl Med 52:169-170, 2011.


Ghoneim IA, Miocinovic R, Stephenson AJGarcia JA, Gong MC, Campbell SC , Hansel DE, Fergany AF. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology 77:867-870, 2011.


Ghosh A, Murugesan G, Chen K, Zhang L, Wang Q, Febbraio M, Anselmo RM, Marchant K, Barnard J, Silverstein RL. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood 117:6355-6366, 2011. PMCID: PMC3122954


Ghosh C, Puvenna V, Gonzalez-Martinez J, Janigro D, Marchi N. Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases. Curr Drug Metab 12:742-749, 2011.


Ghosh SK, Gupta S, Jiang B, Weinberg A. Fusobacterium nucleatum and human beta-defensins modulate the release of antimicrobial chemokine CCL20/macrophage inflammatory protein 3α. Infect Immun 79:4578-4587, 2011. PMCID: PMC3257922


Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, Padmanabhan R, Davidson B, Ganapathi R, Sood AK, Rueda BR, Ambudkar SV, Gottesman MM. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A 108:18708-18713, 2011. PMCID: PMC3219108


Gilligan T. Are we scanning testis cancer patients too often? Cancer 117:4108-4111, 2011.


Gilligan T. Testicular cancer survivorship. Hematol Oncol Clin North Am 25:627-639, 2011.


Gilligan T. The treatment of men with early-stage disease remains an area of significant controversy. Preface. Hematol Oncol Clin North Am 25:xiii-xiv, 2011.


Gilligan T. To better manage cancer symptoms. Cleve Clin J Med 78:24, 2011. PMID: 21199903


Goc A, Al-Husein B, Kochuparambil ST, Liu J, Heston WWD, Somanath PR. PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer. Int J Oncol 38:267-277, 2011.


Goc A, Chaudhary M, Byzova TV, Somanath PR. TGFβ- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). J Cell Physiol 226:3004-3013, 2011. PMCID: PMC3113646


Goodman WA, Jain MK. Length does not matter: a new take on telomerase reverse transcriptase. Arterioscler Thromb Vasc Biol 31:235-236, 2011.


Goodman WA, Young AB, McCormick TS, Cooper KD , Levine AD. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression. J Immunol 186:3336-3345, 2011. PMCID: PMC3133678


Gopal U, Bohonowych JE, Lema-Tome C, Liu A, Garrett-Mayer E, Wang B, Isaacs JS. A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. PLoS One 6:e17649, 2011. PMCID: PMC3050925


Gravitt PE, Belinson JL, Salmeron J, Shah KV. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 129:517-527, 2011.


Greenfield EM, Tatro JM, Smith MV, Schnaser EA, Wu D. PI3Kγ deletion reduces variability in the in vivo osteolytic response induced by orthopaedic wear particles. J Orthop Res 29:1649-1653, 2011.


Gromova P, Rubin BP, Thys A, Erneux C, Vanderwinden JM. Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of cajal. PLoS One 6:e14710, 2011. PMCID: PMC3041753


Gronych J, Korshunov A, Bageritz J, Milde T, Jugold M, Hambardzumyan D, Remke M, Hartmann C, Witt H, Jones DT, Witt O, Heiland S, Bendszus M, Holland EC, Pfister S, Lichter P. An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice. J Clin Invest 121:1344-1348, 2011. PMCID: PMC3069779


Grossman SA, Ye X, Lesser G, Sloan A, Carraway H, Desideri S, Piantadosi S; NABTT CNS Consortium. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res 17:5473-5480, 2011. PMCID: PMC3156964


Grozav AG, Willard BB, Kozuki T, Chikamori K, Micluta MA, Petrescu AJ, Kinter M, Ganapathi R, Ganapathi MK. Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: identification based on artifactual +80-Da modification at this site. Proteomics 11:829-842, 2011.


Guan H, Semaan A, Bandyopadhyay S, Arabi H, Feng J, Fathallah L, Pansare V, Qazi A, Abdul-Karim F, Morris RT, Munkarah AR, Ali-Fehmi R. Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens. Int J Gynecol Cancer 21:654-660, 2011.


Gudino N, Heilman JA, Derakhshan JJ, Sunshine JLDuerk JL, Griswold MA. Control of intravascular catheters using an array of active steering coils. Med Phys 38:4215-4224, 2011.


Guo C, Stark GR. FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-κB. Proc Natl Acad Sci U S A 108:7968-7973, 2011. PMCID: PMC3093511


Gupta K, Chakrabarti A, Rana S, Ramdeo R, Roth BL, Agarwal ML, Tse W, Agarwal MK, Wald DN. Securinine, a myeloid differentiation agent with therapeutic potential for AML. PLoS One 6:e21203, 2011. PMCID: PMC3123298


Guryanova OA, Bao S. How scatter factor receptor c-MET contributes to tumor radioresistance: Ready, set, scatter! J Natl Cancer Inst 103:617-619, 2011.


Guryanova OA, Drazba JA, Frolova EI, Chumakov PM. Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein. J Biol Chem 286:26849-26859, 2011. PMCID: PMC3143645


Guryanova OA, Wu Q, Cheng L, Lathia JD, Huang Z, Yang J, Macswords J, Eyler CE, McLendon RE, Heddleston JM, Shou W, Hambardzumyan DLee J,Hjelmeland ABSloan AE, Bredel M, Stark GRRich JNBao S. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19:498-511, 2011. PMCID: PMC3076106


Gustafson SL, Pfeiffer G, Eng C. A large health system's approach to utilization of the genetic counselor CPT(R) 96040 code. Genet Med 13:1011-1014, 2011.

Hack M, Schluchter M, Andreias L, Margevicius S, Taylor HG, Drotar D, Cuttler L. Change in prevalence of chronic conditions between childhood and adolescence among extremely low-birth-weight children. JAMA 306:394-401, 2011.


Haddad AShepard D. Geriatric oncology and palliative medicine. Semin Oncol 38:362-366, 2011.


Hakenewerth AM, Millikan RC, Rusyn I, Herring AH, North KE, Barnholtz-Sloan JS , Funkhouser WF, Weissler MC, Olshan AF. Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 20:2438-2449, 2011. PMCID: PMC3210881


Halat S, Eble JN, Grignon DJ, Lacy S, Montironi R, Maclennan GT, Lopez-Beltran A, Tan PH, Baldridge LA, Cheng L. Ectopic prostatic tissue: histogenesis and histopathological characteristics. Histopathology 58:750-758, 2011.


Haldar S, Basu A. Modulation of microRNAs by chemical carcinogens and anticancer drugs in human cancer: potential inkling to therapeutic advantage. Mol Cell Pharmacol 3:135-141, 2011.


Hall MJ, Manne SL, Winkel G, Chung DS, Weinberg DS, Meropol NJ. Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing. Cancer Epidemiol Biomarkers Prev 20:249-254, 2011. PMCID: PMC3076798


Hamaneh MB, Zhang L, Buck M. A direct coupling between global and internal motions in a single domain protein? MD investigation of extreme scenarios. Biophys J 101:196-204, 2011. PMCID: PMC3127171


Hamann I, Unterwalder N, Cardona AE, Meisel C, Zipp F, Ransohoff RM, Infante-Duarte C. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology 133:62-73, 2011. PMCID: PMC3088968


Hambardzumyan D, Cheng YK, Haeno H, Holland EC, Michor F. The probable cell of origin of NF1- and PDGF-driven glioblastomas. PLoS One 6:e24454, 2011. PMCID: PMC3170338


Hambardzumyan D, Parada LF, Holland EC, Charest A. Genetic modeling of gliomas in mice: new tools to tackle old problems. Glia 59:1155-1168, 2011.


Hamilton MD, Cola PA, Terchek JJ, Werner JJStange KC. A novel protocol for streamlined IRB review of practice-based research network (PBRN) card studies. J Am Board Fam Med 24:605-609, 2011. PMID: 21900445


Hansel DE, Paner GP, Nese N, Amin MB. Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula. Hum Pathol 42:1770-1776, 2011.


Hansel DE. Targeting melanoma: endothelin B receptor makes an encore. Sci Transl Med 3:69ec17, 2011.


Harris JP, Capadona JR, Miller RH, Healy BC, Shanmuganathan K, Rowan SJ, Weder C, Tyler DJ. Mechanically adaptive intracortical implants improve the proximity of neuronal cell bodies. J Neural Eng 8:066011, 2011.


Harris SR, Zhang GF, Sadhukhan S, Murphy AM, Tomcik KA, Vazquez EJ, Anderson VE, Tochtrop GPBrunengraber H. Metabolism of levulinate in perfused rat livers and live rats: conversion to the drug of abuse 4-hydroxypentanoate. J Biol Chem 286:5895-5904, 2011. PMCID: PMC3037702


Hattori N, Carrino DA, Lauer ME, Vasanji A, Wylie JD, Nelson CM, Apte SS. Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J Biol Chem 286:34298-34310, 2011. PMCID: PMC3190794


Haus JM, Solomon TP, Lu L, Jesberger JA, Barkoukis H, Flask CA, Kirwan JP. Intramyocellular lipid content and insulin sensitivity are increased following a short-term low-glycemic index diet and exercise intervention. Am J Physiol Endocrinol Metab 301:E511-516, 2011. PMCID: PMC3174532


Hayashi H, Sakai T. Animal models for the study of liver fibrosis: new insights from knockout mouse models. Am J Physiol Gastrointest Liver Physiol 300:G729-G738, 2011. PMCID: PMC3094136


Hdeib A, Sloan AE. Convection-enhanced delivery of (131)I-chTNT-1/B mAB for treatment of high-grade adult gliomas. Expert Opin Biol Ther 11:799-806, 2011.


He H, Liyanarachchi S, Akagi K, Nagy R, Li J, Dietrich RC, Li W, Sebastian N, Wen B, Xin B, Singh J, Yan P, Alder H, Haan E, Wieczorek D, Albrecht B, Puffenberger E, Wang H, Westman JA, Padgett RA, Symer DE, de la Chapelle A. Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I. Science 332:238-240, 2011.


He X, Ni Y, Wang Y, Romigh T, Eng C. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53. Hum Mol Genet 20:80-89, 2011. PMCID: PMC3000677


He X, Wang Y, Zhu J, Orloff M, Eng C. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer Lett 301:168-176, 2011.


Head DR, Jacobberger JW, Mosse C, Jagasia M, Dupont W, Goodman S, Flye L, Shinar A, McClintock-Treep S, Stelzer G, Briggs R, Shults K. Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis. Bone Marrow Res 2011:950934, 2011. PMCID: PMC3200066


Heddleston JM, Hitomi M, Venere M, Flavahan WA, Yang K, Kim Y, Minhas S, Rich JNHjelmeland AB. Glioma stem cell maintenance: the role of the microenvironment. Curr Pharm Des 17:2386-2401, 2011.


Heng DY, Xie W, Bjarnason GA, Vaishampayan U, Tan MH, Knox J, Donskov F, Wood L, Kollmannsberger C, Rini BI, Choueiri TK. Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy. Cancer 117:2637-2642, 2011.


Henkin RE, Del Rowe JD, Grigsby PW, Hartford AC, Jadvar H, Macklis RM, Parker JA, Wong JY, Rosenthal SA. ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources. Clin Nucl Med 36:e72-e80, 2011.


Hill BT, Rybicki L, Bolwell BJ, Smith S, Dean RKalaycio MPohlman B, Tench S, Sobecks R, Andresen S, Copelan ESweetenham J. The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls. Br J Haematol 152:561-569, 2011.


Hill BT, Rybicki L, Smith S, Dean RKalaycio MPohlman BSweetenham J, Tench S, Sobecks R, Andresen S, Copelan EBolwell BJ. Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma. Leuk Lymphoma 52:986-993, 2011.


Hirsch BM, Hao Y, Li X, Wesdemiotis C, Wang Z, Zheng W. A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK). Bioorg Med Chem Lett 21:4753-4757, 2011. PMCID: PMC3146582


Hjelmeland ABLathia JD, Sathornsumetee S, Rich JN. Twisted tango: brain tumor neurovascular interactions. Nat Neurosci 14:1375-1381, 2011.


Hjelmeland ABRich JN. Molecular targeting of neural cancer stem cells: TTAGGG, you're it! Clin Cancer Res 17:3-5, 2011. PMCID: PMC3099413


Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, Macswords J, Lathia JD, McLendon R, Lindner D, Sloan ARich JN. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ 18:829-840, 2011. PMCID: PMC3095828


Hodges KB, Lopez-Beltran A, Maclennan GT, Montironi R, Cheng L. Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management. BJU Int 107:532-537, 2011.


Hood CT, Budd GT, Zakov ZN, Singh AD. Male breast carcinoma metastatic to the choroid: report of 3 cases and review of the literature. Eur J Ophthalmol 21:459-467, 2011.


Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol 29:805-813, 2011. PMCID: PMC3068057


Hosoyama T, Aslam MI, Abraham J, Prajapati SI, Nishijo K, Michalek JE, Zarzabal LA, Nelon LD, Guttridge DC, Rubin BP, Keller C. IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma. Clin Cancer Res 17:2757-2766, 2011. PMCID: PMC3087179


Howard DH, Kenline C, Lazarus HM, LeMaistre CF, Maziarz RT, McCarthy Jr PL, Parsons SK, Szwajcer D, Rizzo JD, Majhail NS. Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results. Health Serv Res 46:1762-1777, 2011.


Hoyos M, Moore L, Williams PS, Zborowski M. The use of a linear Halbach array combined with a step-SPLITT channel for continuous sorting of magnetic species. J Magn Magn Mater 323:1384-1388, 2011. PMCID: PMC3050493


Hsi ED, Lorsbach RB, Fend F, Dogan A. Plasmablastic lymphoma and related disorders. Am J Clin Pathol 136:183-194, 2011.


Hsi ED, Tadmor T. Microenvironment in peripheral T cell lymphomas: macrophages and angiogenesis as targets. Leuk Lymphoma 52:3-4, 2011.


Hsi LC, Kundu S, Palomo J, Xu B, Ficco R, Vogelbaum MA, Cathcart MK. Silencing IL-13Rα2 promotes glioblastoma cell death via endogenous signaling. Mol Cancer Ther 10:1149-1160, 2011. PMCID: PMC3132296


Hsu S, Quattrone M, Ostrom Q, Ryken TC, Sloan AEBarnholtz-Sloan JS . Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study. J Neurosurg Spine 14:742-747, 2011.


Hu H, Krasinskas A, Willis J. Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum. Semin Oncol 38:500-510, 2011.


Hu Z, Gu X, Baraoidan K, Ibanez V, Sharma A, Kadkol S, Munker R, Ackerman S, Nucifora G, Saunthararajah Y. RUNX1 regulates corepressor interactions of PU.1. Blood 117:6498-6508, 2011. PMCID: PMC3123020


Huang E, Rubin BP, Keller C. The long road to immunotherapy for childhood rhabdomyosarcoma. Pediatr Blood Cancer 57:899-901, 2011.


Huang HM, Ismail-Beigi F, Muzic RF Jr. A new Michaelis-Menten-based kinetic model for transport and phosphorylation of glucose and its analogs in skeletal muscle. Med Phys 38:4587-4599, 2011. PMCID: PMC3173937


Huang P, Cheng G, Lu H, Aronica M, Ransohoff RM, Zhou L. Impaired respiratory function in mdx and mdx/utrn+/− mice. Muscle Nerve 43:263-267, 2011. PMCID: PMC3103944


Huang RK, Steinmetz NF, Fu CY, Manchester M, Johnson JE. Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells. Nanomedicine (Lond) 6:55-68, 2011. PMCID: PMC3091364


Huang X, Summers MK, Pham V, Lill JR, Liu J, Lee G, Kirkpatrick DS, Jackson PK, Fang G, Dixit VM. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. Mol Cell 42:511-523, 2011.


Huang Z, Wu Q, Guryanova OA, Cheng L, Shou W, Rich JNBao S. Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol 13:142-152, 2011. PMCID: PMC3076066


Huang Z, Zhou W, Bao S. Role of deubiquitylase HAUSP in stem cell maintenance. Cell Cycle 10:1182-1183, 2011. PMCID: PMC3117131


Hubmacher D, Apte SS. Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function. Cell Mol Life Sci 68:3137-3148, 2011.


Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong FL, Tew WP. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29:3457-3465, 2011.


Husseinzadeh HD, Garcia JA. Therapeutic rationale for mTOR inhibition in advanced renal cell carcinoma. Curr Clin Pharmacol 6:214-221, 2011.


Hussey G, Chaudhury A, Howe PH. Discovery of a metastatic pathway: implications for future cancer treatment. Future Oncol 7:703-705, 2011.


Hussey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, Wilce MC, Merrick WC, Howe PH. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell 41:419-431, 2011. PMCID: PMC3061437


Hutson TE, Bukowski RM, Cowey CL, Figlin R, Escudier B, Sternberg CN. Sequential use of targeted agents in the treatment of renal cell carcinoma. Crit Rev Oncol Hematol 77:48-62, 2011.


Hyun I, Tesar P. Stem cells: cloning advance calls for careful regulation. Nature 478:36-37, 2011.

Intzes S, Wiersma S, Meyerson HJ. Myelomastocytic leukemia with t(8;21) in a 3-year-old child. J Pediatr Hematol Oncol 33:e372-e375, 2011.


Islam AS, Beidelschies MA, Huml A, Greenfield EM. Titanium particles activate toll-like receptor 4 independently of lipid rafts in RAW264.7 murine macrophages. J Orthop Res 29:211-217, 2011. PMCID: PMC3010285


Ithychanda SS, Qin J. Evidence for multisite ligand binding and stretching of filamin by integrin and migfilin. Biochemistry 50:4229-4231, 2011. PMCID: PMC3097901

Jacobberger JW, Sramkoski RM, Stefan T. Multiparameter cell cycle analysis. Methods Mol Biol 699:229-249, 2011.


Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood 118:4472-4479, 2011. PMCID: PMC3204914


Jafarifar F, Yao P, Eswarappa SM, Fox PL. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J 30:1324-1334, 2011. PMCID: PMC3094116


Jamshed S, Fowler DH, Neelapu SS, Dean RM, Steinberg SM, Odom J, Bryant K, Hakim F, Bishop MR. EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 46:676-681, 2011.


Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood 118:3932-3941, 2011. PMCID: PMC3193268


Jankowska AM, Szpurka H, Calabro M, Mohan S, Schade AE, Clemente M, Silverstein RLMaciejewski JP. Loss of expression of neutrophil proteinase-3: a contributory factor in thrombotic risk in paroxysmal nocturnal hemoglobinuria. Haematologica 96:954-962, 2011. PMCID: PMC3128213


Jankowsky A, Guenther UP, Jankowsky E. The RNA helicase database. Nucleic Acids Res 39:D338-D341, 2011. PMCID: PMC3013637


Jankowsky E. RNA helicases at work: binding and rearranging. Trends Biochem Sci 36:19-29, 2011. PMCID: PMC3017212


Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, Wiggins CL, Wingo PA. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol 65(5 Suppl 1):S17-S25.e1-3, 2011.


Jeon O, Krebs M, Alsberg E. Controlled and sustained gene delivery from injectable, porous PLGA scaffolds. J Biomed Mater Res A 98:72-79, 2011.


Jeon O, Powell C, Solorio L, Krebs MD, Alsberg E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. J Control Release 154:258-266, 2011.


Jeong SI, Krebs MD, Bonino CA, Samorezov JE, Khan SA, Alsberg E. Electrospun chitosan-alginate nanofibers with in situ polyelectrolyte complexation for use as tissue engineering scaffolds. Tissue Eng Part A 17:59-70, 2011.


Jha BK, Polyakova I, Kessler P, Dong B, Dickerman B, Sen GCSilverman RH. Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity. J Biol Chem 286:26319-26326, 2011. PMCID: PMC3143594


Jia H, Wang X, Liu F, Guenther UP, Srinivasan S, Anderson JT, Jankowsky E. The RNA helicase Mtr4p modulates polyadenylation in the TRAMP complex. Cell 145:890-901, 2011. PMCID: PMC3115544


Jibaja-Weiss ML, Volk RJ, Granchi TS, Neff NE, Robinson EK, Spann SJ, Aoki N, Friedman LC, Beck JR. Entertainment education for breast cancer surgery decisions: a randomized trial among patients with low health literacy. Patient Educ Couns 84:41-48, 2011.


Jin X, Yazer MH, Chalmers JJ, Zborowski M. Quantification of changes in oxygen release from red blood cells as a function of age based on magnetic susceptibility measurements. Analyst 136:2996-3003, 2011.


Joffe S, Kodish E. Protecting the rights and interests of pediatric stem cell donors. Pediatr Blood Cancer 56:517-519, 2011.


Jones S, Kattan MW. Should decision models drive the decision for prostate biopsy? Urol Oncol 29:235-236, 2011.


Juhasz A, Mittal SK, Lee TH, Deng C, Chak A, Lynch HT. Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma. J Clin Gastroenterol 45:867-871, 2011. PMCID: PMC3189338

Kahana B, Kahana EDeimling G, Sterns S, Vangunten M. Determinants of altered life perspectives among older-adult long-term cancer survivors. Cancer Nurs 34:209-218, 2011.


Kalady MF, Jarrar A, Leach B, Laguardia L, O'malley M, Eng C, Church JM. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 54:164-170, 2011.


Kalaycio MBolwell B, Rybicki L, Absi A, Andresen S, Pohlman BDean RSobecks RCopelan E. BU- vs TBI-based conditioning for adult patients with ALL. Bone Marrow Transplant 46:1413-1417, 2011.


Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, Milburn M. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60:404-413, 2011. PMCID: PMC2950914


Kalhan SC, Uppal SO, Moorman JL, Bennett C, Gruca LL, Parimi PS, Dasarathy S, Serre D, Hanson RW. Metabolic and genomic response to dietary isocaloric protein restriction in the rat. J Biol Chem 286:5266-5277, 2011. PMCID: PMC3037639


Kan CE, Cipriano R, Jackson MW. c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M. Cancer Res 71:6930-6939, 2011.


Kanavy HE, Gerstenblith MR. Ultraviolet radiation and melanoma. Semin Cutan Med Surg 30:222-228, 2011.


Kang W, Qi X, Tresser NJ, Kareta M, Belinson JLRollins AM. Diagnostic efficacy of computer extracted image features in optical coherence tomography of the precancerous cervix. Med Phys 38:107-113, 2011. PMCID: PMC3017583


Kang W, Wang H, Wang Z, Jenkins MW, Isenberg GA, Chak ARollins AM. Motion artifacts associated with in vivo endoscopic OCT images of the esophagus. Opt Express 19:20722-20235, 2011.


Kang Z, Gulen MF, Li X. CNS autoimmune inflammation: RICK must NOD! Immunity 34:3-5, 2011.


Kanika ND, Chang J, Tong Y, Tiplitsky S, Lin J, Yohannes E, Tar M, Chance M, Christ GJ, Melman A, Davies KD. Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways. BJU Int 107:1676-1684, 2011. PMCID: PMC3157237


Kaplan D. Social choice at NIH: the principle of complementarity. FASEB J 25:3763-3764, 2011.


Karabulut K, Akyildiz HY, Lance C, Aucejo F, Mclennan G, Agcaoglu O, Siperstein A, Berber E. Multimodality treatment of neuroendocrine liver metastases. Surgery 150:316-325, 2011.


Karam JA, Rini BI, Varella L, Garcia JADreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC , Wood CG, Tannir NM. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol 185:439-444, 2011.


Kasumov T, Ilchenko S, Li L, Rachdaoui N, Sadigov R, Willard B, McCullough AJ, Previs S. Measuring protein synthesis using metabolic 2H labeling, high-resolution mass spectrometry, and an algorithm. Anal Biochem 412:47-55, 2011.


Kattan MW, Earnshaw SR, McDade CL, Black LK, Andriole GL. Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial. Appl Health Econ Health Policy 9:305-315, 2011.


Kattan MW, Gerds TA. Making and evaluating a statistical prediction model for the absolute risk of prostate cancer recurrence. Cancer 117:5026-5028, 2011.


Kattan MW, Yu C, Salomon L, Vora K, Touijer K, Guillonneau B. Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer. Urology 77:396-401, 2011.


Kattan MW. Doc, what are my chances? A conversation about prognostic uncertainty. Eur Urol 59:224, 2011.


Kattan MW. Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets. Eur Urol 59:566-567, 2011.


Keiler SA, Honda K , Bordeaux JS. Retiform hemangioendothelioma treated with Mohs micrographic surgery. J Am Acad Dermatol 65:233-235, 2011.


Kennedy DJ, Kuchibhotla S, Westfall KM, Silverstein RL, Morton RE, Febbraio M. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res 89:604-613, 2011. PMCID: PMC3028977


Kerner J, Lee K, Hoppel CL. Post-translational modifications of mitochondrial outer membrane proteins. Free Radic Res 45:16-28, 2011.


Ketchart W, Ogba N, Kresak A, Albert JMPink JJMontano MM. HEXIM1 is a critical determinant of the response to tamoxifen. Oncogene 30:3563-3569, 2011. PMCID: PMC3136650


Khan MK, Khan N, Almasan AMacklis R. Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther 4:137-148, 2011. PMCID: PMC3176173


Khan N, Khan MK, Almasan A, Singh AD, Macklis R. The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys 80:645-654, 2011. PMCID: PMC3119033


Khan S, Lakhe-Reddy S, McCarty JH, Sorenson CM, Sheibani N, Reichardt LF, Kim JH, Wang B, Sedor JR, Schelling JR. Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1. Am J Pathol 178:609-620, 2011. PMCID: PMC3070557


Khoury W, Strong SA, Fazio VW, Kiran RP. Factors associated with operative recurrence early after resection for Crohn's disease. J Gastrointest Surg 15:1354-1360, 2011.


Khurana S, Chakraborty S, Cheng X, Su YT, Kao HY. The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells. J Biol Chem 286:1850-1859, 2011. PMCID: PMC3023480


Kikuchi K, Rubin BP, Keller C. Developmental origins of fusion-negative rhabdomyosarcomas. Curr Top Dev Biol 96:33-56, 2011.


Kim J, Hoppel CL. Monolysocardiolipin: improved preparation with high yield. J Lipid Res 52:389-392, 2011. PMCID: PMC3023560


Kim J, Ji M, DiDonato JA, Rackley RR, Kuang M, Sadhukhan PC, Mauney JR, Keay SK, Freeman MR, Liou LS, Adam RM. An hTERT-immortalized human urothelial cell line that responds to anti-proliferative factor. In Vitro Cell Dev Biol Anim 47:2-9, 2011. PMCID: PMC3029472


Kim J, Minkler PE, Salomon RG, Anderson VE, Hoppel CL. Cardiolipin: characterization of distinct oxidized molecular species. J Lipid Res 52:125-135, 2011. PMCID: PMC2999925


Kim K, Dean D, Lu A, Mikos AG, Fisher JP. Early osteogenic signal expression of rat bone marrow stromal cells is influenced by both hydroxyapatite nanoparticle content and initial cell seeding density in biodegradable nanocomposite scaffolds. Acta Biomater 7:1249-1264, 2011. PMCID: PMC3031657


Kim K, Dean D, Wallace J, Breithaupt R, Mikos AG, Fisher JP. The influence of stereolithographic scaffold architecture and composition on osteogenic signal expression with rat bone marrow stromal cells. Biomaterials 32:3750-3763, 2011. PMCID: PMC3075725


Kirkova J, Aktas A, Walsh D, Davis MP. Cancer symptom clusters: clinical and research methodology. J Palliat Med 14:1149-1166, 2011.


Kirkova J, Rybicki L, Walsh D, Aktas A, Davis MP, Karafa MT. The relationship between symptom prevalence and severity and cancer primary site in 796 patients with advanced cancer. Am J Hosp Palliat Care 28:350-355, 2011.


Kish DD, Volokh N, Baldwin WM 3rd, Fairchild RL. Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells. J Immunol 186:2117-2126, 2011.


Klein EA , Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306:1549-1556, 2011.


Klein HG, Dodd RY, Hollinger FB, Katz LM, Kleinman S, McCleary KK, Silverman RH, Stramer SL; for the AABB Interorganizational Task Force on XMRV. Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force. Transfusion 51:654-661, 2011.


Klenotic PA, Page RC, Misra SSilverstein RL. Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system. Protein Expr Purif 80:253-259, 2011. PMCID: PMC3195888


Kluge A, Dabir S, Vlassenbroeck I, Eisenberg R, Dowlati A. Protein inhibitor of activated STAT3 expression in lung cancer. Mol Oncol 5:256-264, 2011. PMCID: PMC3104085


Köhler A, De Filippo K, Hasenberg M, van den Brandt C, Nye E, Hosking MP, Lane TE, Männ L, Ransohoff RM, Hauser AE, Winter O, Schraven B, Geiger H, Hogg N, Gunzer M. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 117:4349-4357, 2011. PMCID: PMC3087483


Kojima S, Nakao S, Young N, Bacigalupo A, Gerard G, Hirano N, Maciejewski J, Deeg J, Marsh J, Zhang FK, Lee JW, Ozawa K. The Third Consensus Conference on the treatment of aplastic anemia. Int J Hematol 93:832-837, 2011.


Kollmannsberger C, Bjarnason G, Burnett P, Creel P, Davis M, Dawson N, Feldman D, George S, Hershman J, Lechner T, Potter A, Raymond E, Treister N, Wood L, Wu S, Bukowski R. Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities. Oncologist 16:543-553, 2011.


Kolthammer JA, Corn DJ, Tenley N, Wu C, Tian H, Wang YLee Z. PET imaging of hepatocellular carcinoma with (18)F-fluoroethylcholine and (11)C-choline. Eur J Nucl Med Mol Imaging 38:1248-1256, 2011.


Kombu RS, Brunengraber H, Puchowicz MA. Analysis of the citric acid cycle intermediates using gas chromatography-mass spectrometry. Methods Mol Biol 708:147-157, 2011.


Komrokji RS, Sekeres MA, List AF. Management of lower-risk myelodysplastic syndromes: the art and evidence. Curr Hematol Malig Rep 6:145-153, 2011.


Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr 56:64-68, 2011. PMCID: PMC3017346


Koroukian SM, Bakaki PM, Beaird H, Earle CC, Cooper GS. Cancer stage comparison between dual Medicare-Medicaid eligibles using Medicaid as a supplemental health insurance program and low-income nonduals. J Public Health Manag Pract 17:479-491, 2011.


Koroukian SM, Bakaki PM, Schluchter MDOwusu C. Treatment and survival patterns in relation to multimorbidity in patients with locoregional breast and colorectal cancer. J Geriatr Oncol 2:200-208, 2011. PMCID: PMC3140210


Koroukian SM, Scharpf T, Bakaki PM, Madigan E. Identifying comorbidities in home health care patients: does the outcome and assessment information set have incremental value to medicare claims data? Home Health Care Serv Q 30:1-9, 2011.


Krebs MD, Alsberg E. Localized, targeted, and sustained siRNA delivery. Chemistry 17:3054-3062, 2011.


Krishnamurthi SSMeropol NJ. Colorectal carcinoma: overview of clinical research and management 2011. Semin Oncol 38:481-482, 2011.


Krishnamurthy N, Ngam CR, Berdis AJMontano MM. The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites. Oncogene 30:4731-4739, 2011. PMCID: PMC3161170


Krokowski D, Gaccioli F, Majumder M, Mullins MR, Yuan CL, Papadopoulou B, Merrick WC, Komar AA, Taylor D, Hatzoglou M. Characterization of hibernating ribosomes in mammalian cells. Cell Cycle 10:2691-2702, 2011. PMCID: PMC3219539


Krupka TM, Exner AA. Structural parameters governing activity of Pluronic triblock copolymers in hyperthermia cancer therapy. Int J Hyperthermia 27:663-671, 2011.


Kuang Y, Salem N, Tian H, Kolthammer JA, Corn DJ, Wu C, Wang F, Wang Y, Lee Z. Imaging lipid synthesis in hepatocellular carcinoma with [methyl-11C]choline: correlation with in vivo metabolic studies. J Nucl Med 52:98-106, 2011.


Kumar A, Kim CS, Hoffman TA, Naqvi A, Dericco J, Jung SB, Lin Z, Jain MK, Irani K. p53 impairs endothelial function by transcriptionally repressing Kruppel-like factor 2. Arterioscler Thromb Vasc Biol 31:133-141, 2011. PMCID: PMC3064482


Kumar S, Zhang MJ, Li P, Dispenzieri A, Milone GA, Lonial S, Krishnan A, Maiolino A, Wirk B, Weiss B, Freytes CO, Vogl DT, Vesole DH, Lazarus HM, Meehan KR, Hamadani M, Lill M, Callander NS, Majhail NS, Wiernik PH, Nath R, Kamble RT, Vij R, Kyle RA, Gale RP, Hari PN. Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. Blood 118:1979-1988, 2011. PMCID: PMC3158724


Kunos C, Radivoyevitch TAbdul-Karim FW, Faulhaber P. 18F-fluoro-2-deoxy-d-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response. Int J Gynecol Cancer 21:1117-1123, 2011.


Kunos C, Woods C, Colussi VC, Abdul-Karim FW, Waggoner S. Low-dose-rate brachytherapy for treatment of uterine didelphys malignancy. J Clin Oncol 29:e104-e106, 2011.


Kunos CA, Colussi VC, Pink JRadivoyevitch TOleinick NL. Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates. Int J Radiat Oncol Biol Phys 80:1198-1204, 2011. PMCID: PMC3118909


Kunos CA, Ferris G, Pyatka N, Pink JRadivoyevitch T. Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers. Radiat Res 176:425-433, 2011. PMCID: PMC3191339


Kunos CA, Sill MW, Buekers TE, Walker JL, Schilder JM, Yamada SD, Waggoner SE, Mohiuddin M, Fracasso PM. Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group. Gynecol Oncol 120:224-228, 2011. PMCID: PMC3026069


Kutz WE, Wang LW, Bader HL, Majors AK, Iwata K, Traboulsi EI, Sakai LY, Keene DR, Apte SS. ADAMTS10 interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts. J Biol Chem 286:17156-17167, 2011. PMCID: PMC3089559

Lafata JE, Cooper GS, Divine G, Flocke SA , Oja-Tebbe N, Stange KC, Wunderlich T. Patient-physician colorectal cancer screening discussions delivery of the 5A's in practice. Am J Prev Med 41:480-486, 2011.


Lagman RL, Walsh D, Legrand SB, Davis MP. The business of palliative medicine--part 6: clinical operations in a comprehensive integrated program. Am J Hosp Palliat Care 28:75-81, 2011.


Lalonde MS, Lobritz MA, Ratcliff A, Chamanian M, Athanassiou Z, Tyagi M, Wong J, Robinson JA, Karn J, Varani G, Arts EJ. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the tat-transactivating response element (TAR) RNA. PLoS Pathog 7:e1002038, 2011. PMCID: PMC3098202


Lam M, Hsia AH, Liu Y, Guo M, Swick AR, Berlin JC, McCormick TS, Kenney ME, Oleinick NLCooper KD , Baron ED. Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy. Clin Exp Dermatol 36:645-651, 2011. PMCID: PMC3140567


Lam M, Jou PC, Lattif AA, Lee Y, Malbasa CL, Mukherjee PK, Oleinick NL, Ghannoum MA, Cooper KD , Baron ED. Photodynamic therapy with Pc 4 induces apoptosis of Candida albicans. Photochem Photobiol 87:904-909, 2011. PMCID: PMC3139787


Lance C, McLennan G, Obuchowski N, Cheah G, Levitin A, Sands M, Spain J, Srinivas S, Shrikanthan S, Aucejo FN, Kim R, Menon KV. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 22:1697-1705, 2011.


Lane BR, Gill IS, Fergany AF, Larson BT, Campbell SC . Limited warm ischemia during elective partial nephrectomy has only a marginal impact on renal functional outcomes. J Urol 185:1598-1603, 2011.


Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC . Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 185:421-427, 2011.


Langer JE, Agarwal R, Zhuang H, Huang SS, Mandel SJ. Correlation of findings from iodine 123 scan and ultrasonography in the recommendation for thyroid fine-needle aspiration biopsy. Endocr Pract 17:699-706, 2011.


Lathia JD, Gallagher J, Myers JT, Li M, Vasanji A, McLendon RE, Hjelmeland ABHuang AYRich JN. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS One 6:e24807, 2011. PMCID: PMC3178553


Lathia JD, Heddleston JM, Venere M, Rich JN. Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 8:482-485, 2011.


Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A, Liu L, Eyler CE, Heddleston JM, Wu Q, Minhas S, Soeda A, Hoeppner DJ, Ravin R, McKay RD, McLendon RE, Corbeil D, Chenn A, Hjelmeland AB, Park DM, Rich JN. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis 2:e200, 2011. PMCID: PMC3186899


Lathia JD, Venere M, Rao MS, Rich JN. Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology? Stem Cell Rev 7:227-237, 2011. PMCID: PMC3093710


Lavik E, von Recum H. The role of nanomaterials in translational medicine. ACS Nano 5:3419-3424, 2011. PMCID: PMC3110679


Lazarus HM, Sommers SR, Arfons LM, Fu P, Ataergin SA, Kaye NM, Liu F, Kindwall-Keller TLCooper BWLaughlin MJ, Creger RJ, Barr PMGerson SL,Kaplan D. Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts. Biol Blood Marrow Transplant 17:970-978, 2011.


Lee HY, Lundquist M, Ju E, Luo X, Townsend A. Colorectal cancer screening disparities in Asian Americans and Pacific Islanders: which groups are most vulnerable? Ethn Health 16:501-518, 2011.


Lee JB, Jeong SI, Bae MS, Heo DN, Yang DH, Kim CH, Alsberg E, Kwon IK. Highly porous electrospun nanofibers enhanced by ultra-sonication for improved cellular infiltration. Tissue Eng Part A 17:2695-2702, 2011.


Lee K, Kerner J, Hoppel CL. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J Biol Chem 286:25655-25662, 2011. PMCID: PMC3138250


Lee KM, McKimmie CS, Gilchrist DS, Pallas KJ, Nibbs RJ, Garside P, McDonald V, Jenkins C, Ransohoff R, Liu L, Milling S, Cerovic V, Graham GJ. D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 118:6220-6229, 2011. PMCID: PMC3234674


Lee X, Hu Y, Zhang Y, Yang Z, Shao Z, Qiu M, Pepinsky B, Miller RH, Mi S. Oligodendrocyte differentiation and myelination defects in OMgp null mice. Mol Cell Neurosci 46:752-761, 2011.


Lee Y, Baron ED. Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg 30:199-209, 2011.


Lee YH, Schiemann WP. Fibromodulin suppresses nuclear factor-κB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosis. J Biol Chem 286:6414-6422, 2011. PMCID: PMC3057796


Leong SP, Kim J, Ross M, Faries M, Scoggins CR, Rich Metz WL, Cope FO, Orahood RC. A phase 2 study of (99m)tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol 18:961-969, 2011. PMCID: PMC3071527


Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Wiktor-Jedrzejczak W, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood 117:3294-3301, 2011. PMCID: PMC3069671


Li J, Davis MP, Gamier P. Palliative medicine: barriers and developments in mainland China. Curr Oncol Rep 13:290-294, 2011.


Li J, Horstman B, Chen Y. Detecting epistatic effects in association studies at a genomic level based on an ensemble approach. Bioinformatics 27:i222-i229, 2011. PMCID: PMC3117367


Li M, Chang CJ, Lathia JD, Wang L, Pacenta HL, Cotleur A, Ransohoff RM. Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells. Glia 59:108-118, 2011.


Li M, Ye C, Fu W, Elston RC, Lu Q. Detecting genetic interactions for quantitative traits with U-statistics. Genet Epidemiol 35:457-468, 2011.


Li W, Bian F, Chaudhuri P, Mao X, Brunengraber H, Yu X. Delineation of substrate selection and anaplerosis in tricarboxylic acid cycle of the heart by 13C NMR spectroscopy and mass spectrometry. NMR Biomed 24:176-187, 2011. PMCID: PMC3086566


Li X, Li J. Haplotype reconstruction in large pedigrees with untyped individuals through IBD inference. J Comput Biol 18:1411-1421, 2011. PMCID: PMC3216110


Liang R, Wallace AR, Schadendorf D, Rubin BP. The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma. Pigment Cell Melanoma Res 24:714-723, 2011.


Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, Paruchuri K, Mahabeleshwar GH, Dalmas E, Venteclef N, Flask CAKim J, Doreian BW, Lu KQ, Kaestner KH, Hamik A, Clément K, Jain MK. Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest 121:2736-2749, 2011. PMCID: PMC3223832


Lim JH, Liu Y, Reineke E, Kao HY. Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover. J Biol Chem 286:44403-44411, 2011. PMCID: PMC3248013


Lim JW, Ashing-Giwa KT. Examining the effect of minority status and neighborhood characteristics on cervical cancer survival outcomes. Gynecol Oncol 121:87-93, 2011.


Limbach AL, Ni Y, Huang J, Eng CMagi-Galluzzi C. Adenomatoid tumour of the adrenal gland in a patient with germline SDHD mutation: a case report and review of the literature. Pathology 43:495-498, 2011.


Lin N, Li X, Cui K, Chepelev I, Tie F, Liu B, Li G, Harte P, Zhao K, Huang S, Zhou L. A barrier-only boundary element delimits the formation of facultative heterochromatin in Drosophila melanogaster and vertebrates. Mol Cell Biol 31:2729-2741, 2011. PMCID: PMC3133385


Lin P, Correa D, Lin Y, Caplan AI . Polybrene inhibits human mesenchymal stem cell proliferation during lentiviral transduction. PLoS One 6:e23891, 2011. PMCID: PMC3162604


Lin Y, Cheung P, Roth JC, Wilson DLGerson SL. Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cells. Mol Ther 19:1342-1352, 2011. PMCID: PMC3129550


Linder P, Jankowsky E. From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol 12:505-516, 2011.


Linderman GC, Patel VN, Chance MR, Bebek G. BiC: a web server for calculating bimodality of coexpression between gene and protein networks. Bioinformatics 27:1174-1175, 2011. PMCID: PMC3072551


Liu C, Swaidani S, Qian W, Kang Z, Sun P, Han Y, Wang C, Gulen MF, Yin W, Zhang C, Fox PL, Aronica M, Hamilton TAMisra S, Deng J, Li X. A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation. Sci Signal 4:ra72, 2011.


Liu H, Zhang X, Wu X, Jiang L, Burda C, Zhu JJ. Rapid sonochemical synthesis of highly luminescent non-toxic AuNCs and Au@AgNCs and Cu (II) sensing. Chem Commun (Camb) 47:4237-4239, 2011.


Liu J, Fukuda K, Xu Z, Ma YQ, Hirbawi J, Mao X, Wu C, Plow EFQin J. Structural basis of phosphoinositide binding to kindlin-2 protein pleckstrin homology domain in regulating integrin activation. J Biol Chem 286:43334-43342, 2011. PMCID: PMC3234820


Liu JH, Zanotti KM. Management of the adnexal mass. Obstet Gynecol 117:1413-1428, 2011; Reply 118:956-957, 2011.


Liu X, Qu CK. Protein tyrosine phosphatase SHP-2 (PTPN11) in hematopoiesis and leukemogenesis. J Signal Transduct 2011:195239, 2011. PMCID: PMC3135119


Liu Z, Yang A, Wang Z, Bunting KD, Davuluri G, Green MR, Devireddy L. Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24P3. J Biol Chem 286:20606-20614, 2011. PMCID: PMC3121516


Ljungberg B, Campbell SC , Cho HY, Jacqmin D, Lee JE, Weikert S, Kiemeney LA. The epidemiology of renal cell carcinoma. Eur Urol 60:615-621, 2011.


Lobritz MA, Lassen KG, Arts EJ. HIV-1 replicative fitness in elite controllers. Curr Opin HIV AIDS 6:214-220, 2011.


Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS. Pregnancy after hematopoietic cell transplantation: a report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 17:157-166, 2011. PMCID: PMC3017731


Lorsbach RB, Hsi ED, Dogan A, Fend F. Plasma cell myeloma and related neoplasms. Am J Clin Pathol 136:168-182, 2011.


Lu H, Huang D, Ransohoff RM, Zhou L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J 25:3344-3355, 2011. PMCID: PMC3177578


Lu H, Huang D, Saederup N, Charo IF, Ransohoff RM, Zhou L. Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J 25:358-369, 2011. PMCID: PMC3005436


Lu M, Banerjee S, Saidel GM, Yu X. Regulation of cytosolic and mitochondrial oxidation via malate-aspartate shuttle: an observation using dynamic 13C NMR spectroscopy. Adv Exp Med Biol 701:185-192, 2011.


Lu X, Guo H, Molter J, Miao H, Gerber L, Hu Y, Barnes EL, Vogel H, Lee ZLuo GWang B. Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liver. J Hepatol 55:96-102, 2011.


Lu X, Lou HLuo G. A Blm-Recql5 partnership in replication stress response. J Mol Cell Biol 3:31-38, 2011. PMID: 21278449


Luo X, Prior M, He W, Hu X, Tang X, Sheng W, Yadav S, Kiryu-Seo S, Miller R, Trapp BD, Yan R. Cleavage of neuregulin-1 by BACE1 or ADAM10 produces differential effects on myelination. J Biol Chem 286:23967-23974, 2011. PMCID: PMC3129178


Luthra P, Sun D, Silverman RH, He B. Activation of IFN-β expression by a viral mRNA through RNase L and MDA5. Proc Natl Acad Sci U S A 108:2118-2123, 2011. PMCID: PMC3033319


Lyons JA, Woods C, Galanopoulos N, Silverman P. Emerging radiation techniques for early-stage breast cancer after breast-conserving surgery. Future Oncol 7:915-925, 2011.

Ma DJ, Guo S, Shah SN, Srinivas SM, Macklis RM. The role of functional imaging in radiotherapy planning and management for gynecologic malignancies. PET Clin 6:195-205, 2011.


Mackenzie MJ, Rini BIElson P, Schwandt A, Wood L, Trinkhaus M, Bjarnason G, Knox J. Temsirolimus in VEGF-refractory metastatic renal cell carcinoma. Ann Oncol 22:145-148, 2011.


Maclennan GT, Cheng L. Tubulocystic carcinoma of the kidney. J Urol 185:2348-2349, 2011.


Maeda T, Sakabe T, Sunaga A, Sakai K, Rivera AL, Keene DR, Sasaki T, Stavnezer E, Iannotti J, Schweitzer R, Ilic D, Baskaran HSakai T. Conversion of mechanical force into TGF-β-mediated biochemical signals. Curr Biol 21:933-941, 2011. PMCID: PMC3118584


Magi-Galluzzi C, Tsusuki T, Elson P, Simmerman K, Lafargue C, Esgueva R, Klein E, Rubin MA, Zhou M. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients. Prostate 71:489-497, 2011.


Mahabeleshwar GH, Kawanami D, Sharma N, Takami Y, Zhou G, Shi H, Nayak L, Jeyaraj D, Grealy R, White M, McManus R, Ryan T, Leahy P, Lin Z, Haldar SM, Atkins GB, Wong HR, Lingrel JB, Jain MK. The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock. Immunity 34:715-728, 2011. PMCID: PMC3103656


Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. Bone Marrow Transplant 46:385-392, 2011. PMCID: PMC2978251


Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood 117:316-322, 2011. PMCID: PMC3037753


Major JM, Klonoff-Cohen HS, Pierce JP, Slymen DJ, Saltzstein SL, Macera CA, Mercola D, Kattan MW. Prostate cancer postoperative nomogram scores and obesity. PLoS One 6:e17382, 2011. PMCID: PMC3044730


Majumdar A, Petrescu AD, Xiong Y, Noy N. Nuclear translocation of cellular retinoic acid-binding protein II is regulated by retinoic acid-controlled SUMOylation. J Biol Chem 286:42749-42757, 2011. PMCID: PMC3234969


Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H, Przychodzen B, Prince C, Nicoll J, Siddaiah H, Shaik M, Szpurka H, Hsi E,Advani A, Paquette R, Maciejewski JP. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood 117:e198-e206 2011. PMCID: PMC3110035


Makishima H, Maciejewski JP. Pathogenesis and consequences of uniparental disomy in cancer. Clin Cancer Res 17:3913-3923, 2011.


Malik S, Bolwell B, Rybicki L, Copelan O, Duong H, Dean RSobecks RKalaycio MSweetenham JPohlman B, Andresen S, Tench S, Koo A, Figueroa P, Copelan E. Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation. Bone Marrow Transplant 46:1519-1525, 2011.


Malinin NL, West XZ, Byzova TV. Oxidation as "the stress of life." Aging (Albany NY) 3:906-910, 2011. PMCID: PMC3227455


Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW, Remzi FH. A novel data-driven prognostic model for staging of colorectal cancer. J Am Coll Surg 213:579-588.e2, 2011.


Manilich EA, Ozsoyoglu ZM, Trubachev V, Radivoyevitch T. Classification of large microarray datasets using fast random forest construction. J Bioinform Comput Biol 9:251-267, 2011.


Manola J, Royston P, Elson P, McCormack JB, Mazumdar M, Négrier S, Escudier B, Eisen T, Dutcher J, Atkins M, Heng DY, Choueiri TK, Motzer R, Bukowski R; for the International Kidney Cancer Working Group. Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the International Kidney Cancer Working Group. Clin Cancer Res 17:5443-5450, 2011.


Marina O, Suh JH , Reddy CA, Barnett GH, Vogelbaum MAPeereboom DM, Stevens GH, Elinzano H, Chao ST . Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. J Neurosurg 115:220-229, 2011.


Marinis JM, Homer CR, McDonald CAbbott DW. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses. J Biol Chem 286:1938-1950, 2011. PMCID: PMC3023490


Marko NF, Quackenbush J, Weil RJ. Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data. PLoS One 6:e20826, 2011. PMCID: PMC3145641


Marko NF, Suh JH , Chao ST , Barnett GHVogelbaum MA, Toms S, Weil RJ, Angelov L. Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer. J Neurooncol 104:817-824, 2011.


Marko NF, Weil RJ. A comparative effectiveness analysis of alternate strategies to assess hypothalamic-pituitary-adrenal axis function after microsurgical resection of pituitary tumors. Neurosurgery 68:1576-1585, 2011.


Marko NF, Weil RJ. Medical oncology: patients with brain metastases in early-phase trials. Nat Rev Clin Oncol 8:390-391, 2011.


Marques CP, Kapil P, Hinton DR, Hindinger C, Nutt SL, Ransohoff RM, Phares TW, Stohlman SA, Bergmann CC. CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis. J Virol 85:6136-6147, 2011. PMCID: PMC3126522


Marshall JR, Tangen CM, Sakr WA, Wood DP Jr, Berry DL, Klein EA , Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM Jr. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 4:1761-1769, 2011. PMCID: PMC3208719


Martires KJ, Domingo DS, Hsia A, Fu PCooper KD , Baron ED. Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure. Exp Dermatol 20:280-282, 2011.


Marvin J, Swaminathan S, Kraker G, Chadburn A, Jacobberger J, Goolsby C. Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML. Blood 117:e120-e130, 2011. PMCID: PMC3087538


Masuno K, Haldar SM, Jeyaraj D, Mailloux CM, Huang X, Panettieri RA Jr, Jain MK, Gerber AN. Expression profiling identifies Klf15 as a glucocorticoid target that regulates airway hyperresponsiveness. Am J Respir Cell Mol Biol 45:642-649, 2011. PMCID: PMC3175579


Mateescu GD, Ye A, Flask CA, Erokwu B, Duerk JL. In vivo assessment of oxygen consumption via Deuterium Magnetic Resonance. Adv Exp Med Biol 915:193-199, 2011.


Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, Tewari M, Liu A, Vessella R, Rostomily R, Born D, Horwitz M, Ware C, Blau CA, Cleary MA, Rich JN, Ruohola-Baker H. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71:4640-4652, 2011. PMCID: PMC3129496


Matsui K, Parameswaran N, Bagheri N, Willard BGupta N. Proteomics analysis of the ezrin interactome in B cells reveals a novel association with Myo18aα. J Proteome Res 10:3983-3992, 2011. PMCID: PMC3181492


Mayr NA, Huang Z, Sohn JW, Lo SS, Teh BS, Lu JJ, Grecula JC, Kunos C. Emerging application of stereotactic body radiation therapy for gynecologic malignancies. Expert Rev Anticancer Ther 11:1071-1077, 2011.


Mazanec PDaly BJ, Ferrell BR, Prince-Paul M. Lack of communication and control: experiences of distance caregivers of parents with advanced cancer. Oncol Nurs Forum 38:307-313, 2011. PMCID: PMC3164591


Mazanec SR, Daly BJ, Douglas S, Musil C. Predictors of psychosocial adjustment during the postradiation treatment transition. West J Nurs Res 33:540-559, 2011.


Mazanec SR, Daly BJ, Douglas SL, Lipson AR. Work productivity and health of informal caregivers of persons with advanced cancer. Res Nurs Health 34:483-495, 2011.


Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Cancer Res 71:5904-5914, 2011. PMCID: PMC3165104


Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Oncotarget 2:638-645, 2011. PMCID: PMC3248207


Mazumdar T, Devecchio J, Shi T, Jones J, Agyeman A, Houghton JA. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res 71:1092-1102, 2011. PMCID: PMC3032813


McCabe NP, Kerr BA, Madajka M, Vasanji A, Byzova TV. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer. Neoplasia 13:31-39, 2011. PMCID: PMC3022426


McCrae K. Immune thrombocytopenia: no longer 'idiopathic'. Cleve Clin J Med 78:358-373, 2011. PMID: 21632906


McCrae KR. Sutton's law and anti-β2GPI antibodies. Blood 117:3253-3255, 2011.


McHaffie DR, Chabot P, Dagnault A, Suh JH , Fortin MA, Chang E, Timmerman R, Souhami L, Grecula J, Nabid A, Schultz C, Werner-Wasik M, Gaspar LE, Brachman D, Mody T, Mehta MP. Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: a multi-institutional phase II trial. J Neurooncol 105:301-308, 2011.


McLendon RE, Rich JN. Glioblastoma stem cells: a neuropathologist's view. J Oncol 2011:397195, 2011. PMCID: PMC2971570


McNally AK, Anderson JM. Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells. Exp Mol Pathol 91:673-681, 2011. PMCID: PMC3220734


McNally AK, Anderson JM. Macrophage fusion and multinucleated giant cells of inflammation. Adv Exp Med Biol 713:97-111, 2011.


Mehlman MJ, Berg JW, Juengst ETKodish E. Ethical and legal issues in enhancement research on human subjects. Camb Q Healthc Ethics 20:30-45, 2011.


Meropol NJ, Daly MB, Vig HS, Manion FJ, Manne SL, Mazar C, Murphy C, Solarino N, Zubarev V. Delivery of internet-based cancer genetic counseling services to patients' homes: a feasibility study. J Telemed Telecare 17:36-40, 2011. PMCID: PMC3263376


Meropol NJ. Ongoing challenge of stage II colon cancer. J Clin Oncol 29:3346-3348 2011.


Mester JL, Tilot AK, Rybicki LA, Frazier TW 2nd, Eng C. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet 19:763-768, 2011. PMCID: PMC3137495


Meyerson HJ, Bailey J, Miedler J, Olobatuyi F. Marginal zone B cell lymphomas with extensive plasmacytic differentiation are neoplasms of precursor plasma cells. Cytometry B Clin Cytom 80:71-82, 2011.


Miao J, Wong WC, Narayan S, Huo D, Wilson DL. Modeling non-stationarity of kernel weights for k-space reconstruction in partially parallel imaging. Med Phys 38:4760-4773, 2011. PMCID: PMC3172865


Miao J, Wong WC, Narayan S, Wilson DL. K-space reconstruction with anisotropic kernel support (KARAOKE) for ultrafast partially parallel imaging. Med Phys 38:6138-6142, 2011. PMCID: PMC3221708


Mickelson DM, Sproat L, Dean RSobecks R, Rybicki L, Kalaycio MPohlman BSweetenham J, Andresen S, Bolwell BCopelan EA. Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. Bone Marrow Transplant 46:84-89, 2011.


Miller RHTesar PJ. Tracking down the human myelinating cell. Nat Biotechnol 29:881-883, 2011.


Miller RH. Unwrapping HDAC1 and HDAC2 functions in Schwann cell myelination. Nat Neurosci 14:401-403, 2011.


Min B. Deleting Mcl-1 in mast cells: getting 2 birds with 1 stone. Blood 118:6729-6730, 2011.


Mines D, Gu Y, Kou TD, Cooper GS. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf 20:111-118, 2011.


Miocinovic R, Berglund RK, Stephenson AJ J, Jones JS, Fergany A, Kaouk J, Klein EA . Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment. Urology 77:946-950, 2011; Reply: 78:725, 2011.


Miocinovic R, Gong MC, Ghoneim IA, Fergany AF, Hansel DEStephenson AJ J. Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study. J Urol 186:1269-1273, 2011.


Miocinovic R, Jones JS, Pujara AC, Klein EA , Stephenson AJ J. Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria. Urology 77:980-984, 2011.


Miyagi M, Wan Q, Ahmad MF, Gokulrangan G, Tomechko SE, Bennett B, Dealwis C. Histidine hydrogen-deuterium exchange mass spectrometry for probing the microenvironment of histidine residues in dihydrofolate reductase. PLoS One 6:e17055, 2011. PMCID: PMC3040192


Moline J, Eng C. Multiple endocrine neoplasia type 2: an overview. Genet Med 13:755-764, 2011.


Molitoris JK, McColl KS, Distelhorst CW. Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of bim and initiation of apoptosis. Mol Endocrinol 25:409-420, 2011. PMCID: PMC3045743


Molitoris JK, McColl KS, Swerdlow S, Matsuyama M, Lam M, Finkel TH, Matsuyama SDistelhorst CW. Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes. J Biol Chem 286:30181-30189, 2011. PMCID: PMC3191057


Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Díaz Uriarte R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C, Xu-Monette Z, Young KH, Piris MA. miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood 118:1034-1040, 2011.


Moore CS, Milner R, Nishiyama A, Frausto RF, Serwanski DR, Pagarigan RR, Whitton JL, Miller RH, Crocker SJ. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci 31:6247-6254, 2011. PMCID: PMC3090636


Moran BJ, Derose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP , Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ Jr, Yamada Y, Merrick GS; Expert Panel on Radiation Oncology-Prostate. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol 34:636-647, 2011.


Morgan MA, Sill MW, Fujiwara K, Greer B, Rubin SC, Degeest K, Yamada SD, Waggoner S, Coleman RL, Walker JL, Mannel RS. A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 121:264-268, 2011. PMCID: PMC3081997


Morgensztern D, Pennell NA, Subramanian J, Govindan R. Summary of presentations from the 46th annual meeting of the American Society of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer. Clin Lung Cancer 12:94-99, 2011.


Moriya K, Bae E, Honda K , Sakai K, Sakaguchi T, Tsujimoto I, Kamisoyama H, Keene DR, Sasaki T, Sakai T. A fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling. Gastroenterology 140:1653-1663, 2011. PMCID: PMC3081910


Morris-Stiff G, Falk GA, Joyce D, Rubin B, Chalikonda S. Primary omental haemangiopericytoma. BMJ Case Rep 2011:bcr.03.2011.4041, 2011.


Motea EA, Lee I, Berdis AJ. Quantifying the energetic contributions of desolvation and π-electron density during translesion DNA synthesis. Nucleic Acids Res 39:1623-1637, 2011. PMCID: PMC3045600


Moxley KM, Fader AN, Rose PG, Case AS, Mutch DG, Berry E, Schink JC, Kim CH, Chi DS, Moore KN. Malignant melanoma of the vulva: an extension of cutaneous melanoma? Gynecol Oncol 122:612-617, 2011.


Mueller S, Polley MY, Lee B, Kunwar S, Pedain C, Wembacher-Schröder E, Mittermeyer S, Westphal M, Sampson JH, Vogelbaum MA, Croteau D, Chang SM. Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol 101:267-277, 2011. PMCID: PMC2996533


Mugwanya KK, Whalen C, Celum C, Nakku-Joloba E, Katabira E, Baeten JM. Circumcision of male children for reduction of future risk for HIV: acceptability among HIV serodiscordant couples in Kampala, Uganda. PLoS One 6:e22254, 2011. PMCID: PMC3140501


Mulligan GB, Eray E, Faiman C, Gupta M, Pineyro MM, Makdissi A, Suh JH , Masaryk TJ, Prayson R, Weil RJ, Hamrahian AH. Reduction of false-negative results in inferior petrosal sinus sampling with simultaneous prolactin and corticotropin measurement. Endocr Pract 17:33-40, 2011.


Murphy ES, Barnett GHVogelbaum MA, Neyman G, Stevens GH, Cohen BH, Elson P, Vassil AD, Suh JH . Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas. J Neurosurg 114:432-440, 2011.


Murphy ES, Suh JH . Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys 79:985-997, 2011.


Mutetwa B, Fryzek J, Du Y, Yong M, Sekeres MA, Taioli E. Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western Pennsylvania. Leuk Lymphoma 52:265-272, 2011.


Muzic RF Jr, Chandramouli V, Huang HM, Wu C, Wang Y, Ismail-Beigi F. Analysis of metabolism of 6FDG: a PET glucose transport tracer. Nucl Med Biol 38:667-674, 2011. PMCID: PMC3128789

Nagy R, Ganapathi S, Comeras I, Peterson C, Orloff M, Porter K, Eng C, Ringel MD, Kloos RT. Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid 21:505-510, 2011. PMCID: PMC3092722


Nair S, Kashyap R, Laboisse C, Hopfer U, Gratzl M. Time- resolved release of calcium from an epithelial cell monolayer during mucin secretion. Eur Biophys J 40:165-174, 2011.


Najm FJ, Chenoweth JG, Anderson PD, Nadeau JH, Redline RW, McKay RD, Tesar PJ. Isolation of epiblast stem cells from preimplantation mouse embryos. Cell Stem Cell 8:318-325, 2011. PMCID: PMC3073125


Najm FJ, Zaremba A, Caprariello AV, Nayak S, Freundt EC, Scacheri PCMiller RHTesar PJ. Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells. Nat Methods 8:957-962, 2011.


Nakajima T, Mitsunaga M, Bander NH, Heston WD , Choyke PL, Kobayashi H. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody- indocyanine green (ICG) conjugate. Bioconjug Chem 22:1700-1705, 2011. PMCID: PMC3157565


Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, Loblaw DA, Narod SA. Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators. J Clin Oncol 29:2959- 2964, 2011.


Nam RK, Zhang W, Siminovitch K, Shlien A, Kattan MW, Klotz LH, Trachtenberg J, Lu Y, Zhang J, Yu C, Toi A, Loblaw DA, Venkateswaran V, Stanimirovic A, Sugar L, Malkin D, Seth A, Narod SA. New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. Cancer Biol Ther 12:997-1004, 2011.


Narayan S, Huang F, Johnson D, Gargesha M, Flask CAZhang GQWilson DL. Fast lipid and water levels by extraction with spatial smoothing (FLAWLESS): three-dimensional volume fat/water separation at 7 Tesla. J Magn Reson Imaging 33:1464-1473, 2011.


Nayak L, Jain MK. Angiogenesis: the HETE is on. Blood 118:5367 -5369, 2011.


Nayak L, Lin Z, Jain MK. "Go with the flow": how Krüppel- like factor 2 regulates the vasoprotective effects of shear stress. Antioxid Redox Signal 15:1449-1461, 2011. PMCID: PMC3144441


Negrotto S, Hu Z, Alcazar O, Ng KP, Triozzi PLindner DRini BSaunthararajah Y. Noncytotoxic differentiation treatment of renal cell cancer. Cancer Res 71:1431-1441, 2011.


Nelson TE, Hao C, Manos J, Ransohoff RM, Gruol DL. Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression. Brain Behav Immun 25(Suppl 1):S106-S119, 2011.


Neumann HP, Sullivan M, Winter A, Malinoc A, Hoffmann MM, Boedeker CC, Bertz H, Walz MK, Moeller LC, Schmid KW, Eng C. Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. J Clin Endocrinol Metab 96:E1279-E1282, 2011.


Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, Leybaert L, Molnár Z, O'Donnell ME, Povlishock JT, Saunders NR, Sharp F, Stanimirovic D, Watts RJ, Drewes LR. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 12:169-182, 2011.


Newcomer AE, Dylinski D, Rubin BP, Joyce MJ, Hoeltge G, Bershadsky B, Lietman SA. Prognosticators in thigh soft tissue sarcomas. J Surg Oncol 103:85-91, 2011.


Ng KP, Ebrahem Q, Negrotto S, Mahfouz RZ, Link KA, Hu Z, Gu X, Advani AKalaycio MSobecks RSekeres MCopelan ERadivoyevitch T,Maciejewski J, Mulloy JC, Saunthararajah Y. p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. Leukemia 25:1739-1750, 2011.


Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab 96:E2063-E2071, 2011. PMCID: PMC3232626


Nguyen CT, Kattan MW. How to tell if a new marker improves prediction. Eur Urol 60:226-230, 2011.


Nguyen CT, Stephenson AJ J. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors. Hematol Oncol Clin North Am 25:593-604, ix, 2011.


Ni Y, Eng C. Response to Bayley: functional study informs bioinformatic analysis. Am J Hum Genet 88:676, 2011.


Nibbe RK, Chowdhury SA, Koyutürk M, Ewing R, Chance MR. Protein-protein interaction networks and subnetworks in the biology of disease. Wiley Interdiscip Rev Syst Biol Med 3:357-367, 2011.


Nicholls HT, Kowalski G, Kennedy DJ, Risis S, Zaffino LA, Watson N, Kanellakis P, Watt MJ, Bobik A, Bonen A, Febbraio M, Lancaster GI, Febbraio MA. Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue. Diabetes 60:1100-1110, 2011. PMCID: PMC3064084


Nieder ML, McDonald GB, Kida A, Hingorani S, Armenian SH, Cooke KR, Pulsipher MA, Baker KS. National cancer institute-national heart, lung and blood institute/pediatric blood and marrow transplant consortium first international consensus conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. Biol Blood Marrow Transplant 17:1573-1584, 2011. PMCID: PMC3215762


Nock CJ, Brell JM, Bokar JACooney MMCooper B , Gibbons J, Krishnamurthi S, Manda S, Savvides P, Remick SC, Ivy P, Dowlati A. A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors. Invest New Drugs 29:126-130, 2011.


Nock NL, Patrick-Melin A, Cook M, Thompson C, Kirwan JP, Li L. Higher bone mineral density is associated with a decreased risk of colorectal adenomas. Int J Cancer 129:956-964, 2011. PMCID: PMC3125467


Nock NL, Plummer SJ, Thompson CL, Casey G, Li L. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African- Americans. Carcinogenesis 32:748-756, 2011. PMCID: PMC3086700


Nordgren KK, Peng Y, Pelleymounter LL, Moon I, Abo R, Feng Q, Eckloff B, Yee VC, Wieben E, Weinshilboum RM. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics. Drug Metab Dispos 39:2135-2147, 2011. PMCID: PMC3198898


Nutting PA, Crabtree BF, Miller WL, Stange KC, Stewart E, Jaén C. Transforming physician practices to patient-centered medical homes: lessons from the national demonstration project. Health Aff (Millwood) 30:439-445, 2011. PMCID: PMC3140061


Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS , Hu Y, He Q, Luo J, Millikan RC. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Res Treat 129:593-606, 2011.

O'Connor OA, Pro B, Pinter-Brown L, Bartlett N, Popplewell L, Coiffier B, Lechowicz MJ, Savage KJ, Shustov AR, Gisselbrecht C, Jacobsen E, Zinzani PL, Furman R, Goy A, Haioun C, Crump M, Zain JM, Hsi E, Boyd A, Horwitz S. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL Study. J Clin Oncol 29:1182-1189, 2011. PMCID: PMC3083873


O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ. Assessing compliance with National Comprehensive Cancer Network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' Initiative. Clin Colorectal Cancer 10:113-116, 2011.


O'Keefe CL, Sugimori C, Afable M, Clemente M, Shain K, Araten DJ, List A, Epling-Burnette PK, Maciejewski JP. Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria. Leukemia 25:379-382, 2011.


Oliansky DM, Czuczman M, Fisher RI, Irwin FD, Lazarus HM, Omel J, Vose J, Wolff SN, Jones RB, McCarthy PL Jr, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review. Biol Blood Marrow Transplant 17:20-47.e30, 2011.


Olivieri NF, Saunthararajah Y, Thayalasuthan V, Kwiatkowski J, Ware RE, Kuypers FA, Kim HY, Trachtenberg FL, Vichinsky EP; Thalassemia Clinical Research Network. A pilot study of subcutaneous decitabine in β-thalassemia intermedia. Blood 118:2708-2711, 2011. PMCID: PMC3172790


Ondrejka SL, Lai R, Smith SD, Hsi ED. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 96:1121-1127, 2011. PMCID: PMC3148905


Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, Rhea J, Molinaro RJ, Gaughan C, Dong B, Klein EA , Qiu X, Devare S, Schochetman G, Hackett J Jr, Silverman RH, Villinger F. Infection, viral dissemination and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J Virol 85:4547-4557, 2011. PMCID: PMC3126245


Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang YR, Bebek G, Romigh T, Song JH, Wu W, David S, Cheng Y, Meltzer SJ, Eng C. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA 306:410-419, 2011.


Ostrom QT, Barnholtz-Sloan JS . Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep 11:329-335, 2011.


Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D. CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization. Cancer Res 71:3802-3811, 2011.


Owusu CKoroukian SMSchluchter M, Bakaki P, Berger NA. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. J Geriatr Oncol 2:121-129, 2011. PMCID: PMC3173499


Oztug Durer ZA, Kamal JK, Benchaar S, Chance MR, Reisler E. Myosin binding surface on actin probed by hydroxyl radical footprinting and site-directed labels. J Mol Biol 414:204-216, 2011. PMCID: PMC3221818

Paczesny S, Diaz-Ricart M, Carreras E, Cooke KR. Translational research efforts in biomarkers and biology of early transplant-related complications. Biol Blood Marrow Transplant 17(1 Suppl):S101-S108, 2011.


Page RC, Clark JG, Misra S. Structure of filamin A immunoglobulin-like repeat 10 from Homo sapiens. Acta Crystallogr Sect F Struct Biol Cryst Commun 67:871-876, 2011. PMCID: PMC3151117


Paice JA, Erickson-Hurt C, Ferrell B, Coyle N, Coyne PJ, Long CO, Mazanec P, Malloy P, Smith TJ. Providing pain and palliative care education internationally. J Support Oncol 9:129-133, 2011.


Panoskaltsis-Mortari A, Griese M, Madtes DK, Belperio JA, Haddad IY, Folz RJ, Cooke KR; American Thoracic Society Committee on Idiopathic Pneumonia Syndrome. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 183:1262-1279, 2011. PMCID: PMC3266140


Parameswaran N, Matsui K, Gupta N. Conformational switching in ezrin regulates morphological and cytoskeletal changes required for B cell chemotaxis. J Immunol 186:4088-4097, 2011. PMCID: PMC3106416


Parikh PT, Sandhu GS, Blackham KA, Coffey MD, Hsu D, Liu K, Jesberger J, Griswold M, Sunshine JL. Evaluation of image quality of a 32-channel versus a 12-channel head coil at 1.5T for MR imaging of the brain. AJNR Am J Neuroradiol 32:365-373, 2011.


Parvani JG, Taylor MA, Schiemann WP. Noncanonical TGF-β signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia 16:127-146, 2011.


Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M. Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant 17:1869-1873, 2011. PMCID: PMC3217167


Patard JJ, Pignot G, Escudier B, Eisen T, Bex A, Sternberg C, Rini B, Roigas J, Choueiri T, Bukowski R, Motzer R, Kirkali Z, Mulders P, Bellmunt J. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease. Eur Urol 60:684-890, 2011.


Patel AR, Lee BH, Campbell SC , Zhou M, Fergany AF. Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications. Urology 78:1095-1099, 2011.


Patel AR, Stephenson AJ J. Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage? Nat Rev Urol 8:385-392, 2011.


Patil DT, Rubin BP. Gastrointestinal stromal tumor: advances in diagnosis and management. Arch Pathol Lab Med 135:1298-1310, 2011.


Paun O, Lazarus HM. Novel transplant strategies in adults with acute leukemia. Hematol Oncol Clin North Am 25:1319-1339, ix, 2011.


Paustian C, Caspell R, Johnson T, Cohen PA, Shu S, Xu S, Czerniecki BJ, Koski GK. Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells. Hum Immunol 72:24-31, 2011.


Peng Y, Sartini D, Pozzi V, Wilk D, Emanuelli M, Yee VC. Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry 50:7800-7808, 2011.


Pennell NA. Integration of EGFR inhibitors and conventional chemotherapy in the treatment of non-small-cell lung cancer. Clin Lung Cancer 12:350-359, 2011.


Perera HD, Ma YQ, Yang J, Hirbawi J, Plow EFQin J. Membrane binding of the N-terminal ubiquitin-like domain of kindlin-2 is crucial for its regulation of integrin activation. Structure 19:1664-1671, 2011. PMCID: PMC3217186


Perera RH, Krupka TM, Wu H, Traughber B, Dremann D, Broome AMExner AA. Role of Pluronic block copolymers in modulation of heat shock protein 70 expression. Int J Hyperthermia 27:672-681, 2011.


Perera VS, Hao J, Gao M, Gough M, Zavalij PY, Flask CBasilion JP, Huang SD. Nanoparticles of the novel coordination polymer KBi(H2O)2[Fe(CN)6] H2O as a potential contrast agent for computed tomography. Inorg Chem 50:7910-7912, 2011.


Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Sutphen R, McLaughlin J, Narod SA, Goode EL, Schildkraut JM, Fenstermacher D, Phelan CM, Sellers TA. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 20:1131-1145, 2011. PMCID: PMC3111851


Permuth-Wey J, Chen Z, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, …et al; on behalf of the Ovarian Cancer Association Consortium (OCAC). MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 20:1793-1797, 2011. PMCID: PMC3153581


Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res 71:3896-3903, 2011. PMCID: PMC3107389


Phillips-Mason PJ, Craig SE, Brady-Kalnay SM. Should I stay or should I go? Shedding of RPTPs in cancer cells switches signals from stabilizing cell-cell adhesion to driving cell migration. Cell Adh Migr 5:298-305, 2011. PMCID: PMC3210297


Phillips-Mason PJ, Kaur H, Burden-Gulley SM, Craig SE, Brady-Kalnay SM. Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration. J Cell Biochem 112:39-48, 2011. PMCID: PMC3031780


Pickles T, Morris WJ, Kattan MW, Yu C, Keyes M. Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer. Brachytherapy 10:9-14, 2011.


Pilch-Cooper HA, Sieg SF, Hope TJ, Koons A, Escola JM, Offord R, Veazey RS, Mosier DE, Clagett B, Medvik K, Jadlowsky JK, Chance MR, Kiselar JG, Hoxie JA, Collman RG, Riddick NE, Mercanti V, Hartley O, Lederman MM. Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5. Blood 118:1015-1019, 2011. PMCID: PMC3148155


Pirasteh A, Snyder L, Boncher N, Passalacqua M, Rosenblum D, Prologo JD. Cryoablation vs. radiofrequency ablation for small renal masses. Acad Radiol 18:97-100, 2011.


Pitter KL, Galbán CJ, Galbán S, Saeed-Tehrani O, Li F, Charles N, Bradbury MS, Becher OJ, Chenevert TL, Rehemtulla A, Ross BD, Holland EC,Hambardzumyan D. Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma. PLoS One 6:e14545, 2011. PMCID: PMC3022633


Pluskota E, Dowling JJ, Gordon N, Golden JA, Szpak D, West XZ, Nestor C, Ma YQ, Bialkowska K, Byzova TPlow EF. The integrin co-activator Kindlin-2 plays a critical role in angiogenesis in mice and zebrafish. Blood 117:4978-4987, 2011. PMCID: PMC3100704


Pokorski JK, Steinmetz NF. The art of engineering viral nanoparticles. Mol Pharm 8:29-43, 2011. PMCID: PMC3156490


Ponsky LE. Editorial comment [Complications of hand-assisted laparoscopic renal surgery: single-center ten-year experience]. Urology 77:1358, 2011.


Prajapati SI, Kilcoyne A, Samano AK, Green DP, McCarthy SD, Blackman BA, Brady MM, Zarzabal LA, Tatiparthy AK, Sledz TJ, Duong T, Ohshima-Hosoyama S, Giles FJ, Michalek JE, Rubin BP, Keller C. MicroCT-based virtual histology evaluation of preclinical medulloblastoma. Mol Imaging Biol 13:493-499, 2011.


Pretorius RG, Belinson JL, Burchette RJ, Hu S, Zhang X, Qiao YL. Regardless of skill, performing more biopsies increases the sensitivity of colposcopy. J Low Genit Tract Dis 15:180-188, 2011.


Prinz M, Priller J, Sisodia SS, Ransohoff RM. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 13:1227-1235, 2011.


Prosdocimo DA, Jain MK. BMPing up angiogenesis via BMPER. Arterioscler Thromb Vasc Biol 31:2167-2168, 2011.


Provencio JJ, Altay T, Smithason S, Moore SK, Ransohoff RM. Depletion of Ly6G/C(+) cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage. J Neuroimmunol 232:94-100, 2011. PMCID: PMC3053416


Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP,Tiu RV, DiFronzo N, Horowitz MM, Antin JH. Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biol Blood Marrow Transplant 17:291-299, 2011. PMCID: PMC3053041


Punnen S, Hardin J, Cheng I, Klein EA , Witte JS. Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS One 6:e27711, 2011. PMCID: PMC3223211


Pyon YS, Li X, Li J. Cancer progression analysis based on ordinal relationship of cancer stages and co-expression network modularity. Int J Data Min Bioinform 5:233-251, 2011.

Qu Y, Misaghi S, Newton K, Gilmour LL, Louie S, Cupp JE, Dubyak GR, Hackos D, Dixit VM. Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J Immunol 186:6553-6561, 2011.

Radivoyevitch T, Munch-Petersen B, Wang L, Eriksson S. A mathematical model of human thymidine kinase 2 activity. Nucleosides Nucleotides Nucleic Acids 30:203-209, 2011. PMCID: PMC3097248


Rahaman SO, Swat W, Febbraio MSilverstein RL. Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation. J Biol Chem 286:7010-7017, 2011. PMCID: PMC3044957


Rahaman SO, Zhou G, Silverstein RL. Vav protein guanine nucleotide exchange factor regulates CD36 protein-mediated macrophage foam cell formation via calcium and dynamin-dependent processes. J Biol Chem 286:36011-36019, 2011. PMCID: PMC3195569


Rahmathulla G, Barnett GH. Vestibular schwannoma of oscillating size: a case report and review of literature. Surg Neurol Int 2:187, 2011. PMCID: PMC3263002 Rai V, Egelhoff TT. Role of B regulatory subunits of protein phosphatase type 2A in myosin II assembly control in Dictyostelium discoideum. Eukaryot Cell 10:604-610, 2011. PMCID: PMC3127641


Raina R, Nadig V, Patel D, Jegalian A, Silver B, Heyka RJ. Spontaneous perinephric hematoma due to acquired factor X deficiency in AL amyloidosis. NDT Plus 4:101-103, 2011.


Rajab R, Fisher G, Kattan MW, Foster CS, Møller H, Oliver T, Reuter V, Scardino PT, Cuzick J, Berney DM; Transatlantic Prostate Group. An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent. Mod Pathol 24:58-63, 2011.


Rajasekaran K, Chu H, Kumar P, Xiao Y, Tinguely M, Samarakoon A, Kim TW, Li X, Thakar MS, Zhang J, Malarkannan S. Transforming growth factor-beta-activated kinase 1 regulates natural killer cell-mediated cytotoxicity and cytokine production. J Biol Chem 286:31213-31224, 2011. PMCID: PMC3173069


Raju R, Nanjappa V, Balakrishnan L, Radhakrishnan A, Thomas JK, Sharma J, Tian M, Palapetta SM, Subbannayya T, Sekhar NR, Muthusamy B, Goel R, Subbannayya Y, Telikicherla D, Bhattacharjee M, Pinto SM, Syed N, Srikanth MS, Sathe GJ, Ahmad S, Chavan SN, Kumar GS, Marimuthu A, Prasad TS, Harsha HC, Rahiman BA, Ohara O, Bader GD, Sujatha Mohan S, Schiemann WP, Pandey A. NetSlim: high-confidence curated signaling maps. Database (Oxford) 2011:bar032, 2011. PMCID: PMC3263596


Ramirez MS, Adams MD, Bonomo RA, Centrón D, Tolmasky ME. Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identification of structures related to its susceptibility phenotype. Antimicrob Agents Chemother 55:1520-1526, 2011. PMCID: PMC3067174


Ransohoff RM, Stevens B. Neuroscience. How many cell types does it take to wire a brain? Science 333:1391-1392, 2011.


Ransohoff RM. Ageing: blood ties. Nature 477:41-42, 2011.


Ransohoff RM. Microglia and monocytes: 'tis plain the twain meet in the brain. Nat Neurosci 14:1098-1100, 2011.


Rao RD, Cobleigh MA, Gray R, Graham ML 2nd, Norton L, Martino S, Budd GT, Ingle JN, Wood WC. Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group. Med Oncol 28(Suppl 1):39-47, 2011.


Ray PS, Sullivan JC, Jia J, Francis J, Finnerty JR, Fox PL. Evolution of function of a fused metazoan tRNA synthetase. Mol Biol Evol 28:437-447, 2011. PMCID: PMC3002251


Raychaudhuri B, Rayman P, Ireland J, Ko J, Rini BBorden ECGarcia JVogelbaum MAFinke J. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol 13:591-599, 2011. PMCID: PMC3107102


Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-κB induced invasion by gliomas. J Neurooncol 101:227-235, 2011.


Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK, Krieg A, Bedogni B, LaGory E, Weissman IL, Broome-Powell M, Giaccia AJ. VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration. Proc Natl Acad Sci U S A 108:1931-1936, 2011. PMCID: PMC3033256


Reardon DA, Desjardins A, Peters K, Gururangan S, Sampson J, Rich JN, McLendon R, Herndon JE 2nd, Marcello J, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS. Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. J Neurooncol 103:371-379, 2011. PMCID: PMC3102515


Reardon DA, Galanis E, Degroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen PY. Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol 13:353-361, 2011. PMCID: PMC3064608


Reardon DA, Vredenburgh JJ, Coan A, Desjardins A, Peters KB, Gururangan S, Sathornsumetee S, Rich JN, Herndon JE, Friedman HS. Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma. J Neurooncol 105:621-627, 2011.


Ren B, Hale J, Srikanthan S, Silverstein RL. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway. Blood 117:6036-6045, 2011. PMCID: PMC3112047


Repaka A, Chak A. Endoscopic management of Barrett esophagus. Nat Rev Gastroenterol Hepatol 8:582-591, 2011.


Ricart AD, Ashton EA, Cooney MM, Sarantopoulos J, Brell JM, Feldman MA, Ruby KE, Matsuda K, Munsey MS, Medina G, Zambito A, Tolcher AW, Remick SC. A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors. Cancer Chemother Pharmacol 68:959-970, 2011.


Rice BL, Farver CF, Pohlman B, Burkey BB, Parambil JG. Concomitant Castleman's disease and sarcoidosis. Am J Med Sci 341:257-259, 2011.


Richendollar BG, Pohlman BElson PHsi ED. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma. Hum Pathol 42:552-557, 2011.


Rimm DL, Nielsen TO, Jewell SD, Rohrer DC, Broadwater G, Waldman F, Mitchell KA, Singh B, Tsongalis GJ, Frankel WL, Magliocco AM, Lara JF, Hsi ED, Bleiweiss IJ, Badve SS, Chen B, Ravdin PM, Schilsky RL, Thor A, Berry DA. Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues. J Clin Oncol 29:2282-2290, 2011. PMCID: PMC3107745


Rini B, Al-Marrawi MY. Pazopanib for the treatment of renal cancer. Expert Opin Pharmacother 12:1171-1189, 2011.


Rini B. Kidney cancer: does hypothyroidism predict clinical outcome? Nat Rev Urol 8:10-11, 2011.


Rini BI, Angelov L. Nonsystematic approaches to the management of metastatic renal cell carcinoma. Emerg Cancer Ther 2:89-99, 2011.


Rini BICampbell SC , Zhou M. Malignant angiomyolipoma: a rare entity with unusual biology. Oncology (Williston Park) 25:840-841, 2011.


Rini BI, Cohen DP, Lu DR, Chen I, Hariharan S, Gore ME, Figlin RA, Baum MS, Motzer RJ. Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 103:763-773, 2011; author reply 103:1558. PMCID: PMC3086879


Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet 378:1931-1939, 2011.


Rini BI, Schiller JH, Fruehauf JP, Cohen EE, Tarazi JC, Rosbrook B, Bair AH, Ricart AD, Olszanski AJ, Letrent KJ, Kim S, Rixe O. Diastolic blood pressure as a biomarker of axitinib efficacy in solid tumors. Clin Cancer Res 17:3841-3849, 2011.


Rini BI, Stein M, Shannon P, Eddy S, Tyler A, Stephenson JJ Jr, Catlett L, Huang B, Healey D, Gordon M. Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma. Cancer 117:758-767, 2011.


Rini BI. Review: thyroid function abnormalities in patients receiving VEGF-targeted therapy. Clin Adv Hematol Oncol 9:337-338, 2011.


Rini BI. Targeted therapy for patients with renal-cell carcinoma. Lancet Oncol 12:1085-1087, 2011.


Robilotto TJ, Alt DS, von Recum HA, Gray TG. Cytotoxic gold(i)-bearing dendrimers from alkyne precursors. Dalton Trans 40:8083-8085, 2011.


Robinson C, Suh J. In Reply to Dr. Azoury et al [Postoperative radiation for prevention of heterotopic ossification of the elbow]. Int J Radiat Oncol Biol Phys 79:636, 2011.


Robinson MR, Honda KSBordeaux JS. Angiosarcoma in an obese woman with worsening lymphedema after weight-loss and skin-reduction surgeries. J Am Acad Dermatol 65:448-449, 2011.


Rogers LR, Gutierrez J, Scarpace L, Schultz L, Ryu S, Lord B, Movsas B, Honsowetz J, Jain R. Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis. J Neurooncol 101:25-32, 2011.


Rogers LR, Lorusso P, Nadler P, Malik G, Shields A, Kaelin W. Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report. J Neurooncol 101:307-310, 2011.


Ros PR, Goodman ZD. Genetics and imaging of hepatocellular adenomas: 2011 update. Invited commentary. Radiographics 31:1543-1545, 2011.


Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study. Gynecol Oncol 121:542-545, 2011.


Rose PG, Ali S. Commentary on "Is there a real standard for stage IVa cervical cancer?" Gynecol Oncol 123:175, 2011.


Rose PG, Brady MF. EORTC 55971: does it apply to all patients with advanced state ovarian cancer? Gynecol Oncol 120:300-301, 2011.


Rose PG, Monk BJ, Provencher D, Hartney J, Legenne P, Lane S. An open-label, single-arm phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer. Gynecol Oncol 120:38-42, 2011.


Rose PG. Combination therapy: new treatment paradigm for locally advanced cervical cancer? Nat Rev Clin Oncol 8:388-390, 2011.


Rosen LS, Senzer N, Mekhail T, Ganapathi R, Chai F, Savage RE, Waghorne C, Abbadessa G, Schwartz B, Dreicer R. A phase I dose-escalation study of tivantinib (ARQ 197) in adult patients with metastatic solid tumors. Clin Cancer Res 17:7754-7764, 2011.


Rossi CJ Jr, Joe Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP , Frank SJ, Hahn NM, Moran BJ, Rosenthal SA, Merrick G. ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer. Am J Clin Oncol 34:92-98, 2011.


Rubin BP, Nishijo K, Chen HI, Yi X, Schuetze DP, Pal R, Prajapati SI, Abraham J, Arenkiel BR, Chen QR, Davis S, McCleish AT, Capecchi MR, Michalek JE, Zarzabal LA, Khan J, Yu Z, Parham DM, Barr FG, Meltzer PS, Chen Y, Keller C. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 19:177-191, 2011. PMCID: PMC3040414


Rubinstein WS, Acheson LS, O'neill SM, Ruffin MT 4th, Wang C, Beaumont JL, Rothrock N; for the Family Healthware Impact Trial (FHITr) Group. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med 13:956-965, 2011.


Rubinstein WS, O'Neill SM, Rothrock N, Starzyk EJ, Beaumont JL, Acheson LS, Wang C, Gramling R, Galliher JM, Ruffin MT 4th. Components of family history associated with women’s disease perceptions for cancer: a report from the Family Healthware Impact Trial. Genet Med 13:52-62, 2011.


Ruffalo M, Laframboise TKoyutürk M. Comparative analysis of algorithms for next-generation sequencing read alignment. Bioinformatics 27:2790-2796, 2011.


Ruffin MT 4th, Nease DE Jr, Sen A, Pace WD, Wang C, Acheson LS, Rubinstein WS, O'Neill S, Gramling R; Family History Impact Trial (FHITr) Group. Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med 9:3-11, 2011. PMCID: PMC3022039


Ruhe MC, Bobiak SN, Litaker D, Carter CA, Wu L, Schroeder C, Zyzanski SJ, Weyer SM, Werner JJ, Fry RE, Stange KC. Appreciative inquiry for quality improvement in primary care practices. Qual Manag Health Care 20:37-48, 2011.


Rusmevichientong A, Das Gupta J, Elias PS, Silverman RH, Chow SA. Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus. J Virol 85:12830-12834, 2011. PMCID: PMC3209368


Rybicki BA, Neslund-Dudas C, Bock CH, Nock NL, Rundle A, Jankowski M, Levin AM, Beebe-Dimmer J, Savera AT, Takahashi S, Shirai T, Tang D. Red wine consumption is inversely associated with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct levels in prostate. Cancer Prev Res (Phila) 4:1636-1644, 2011. PMCID: PMC3188357

Sadeghi S, Barzi A, Kattan MWMeropol NJ. Screening for lynch syndrome in the general population-letter. Cancer Prev Res (Phila) 4:471, 2011.


Salem M, Garcia JA. Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer. Curr Oncol Rep 13:92-96, 2011.


Salem M, Gilligan T. Serum tumor markers and their utilization in the management of germ-cell tumors in adult males. Expert Rev Anticancer Ther 11:1-4, 2011. PMID: 21166503


Salem N, Kuang Y, Corn D, Erokwu B, Kolthammer JA, Tian H, Wu C, Wang F, Wang YLee Z. [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma. Mol Imaging Biol 13:140-151, 2011.


Salman H, Lazarus HM. Plerixafor for autologous CD34+ cell mobilization. Core Evid 6:23-29, 2011. PMCID: PMC3065558


Samplaski MK, Heston WElson PMagi-Galluzzi CHansel DE. Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Mod Pathol 24:1521-1529, 1531, 2011.


Samplaski MK, Zhou M, Lane BR, Herts B, Campbell SC . Renal mass sampling: an enlightened perspective. Int J Urol 18:5-19, 2011.


Sandadi S, Frasure HE, Broderick MJ, Waggoner SE, Miller JA, von Gruenigen VE. The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol Oncol 123:351-355, 2011.


Saraf S, Farooqui M, Infusino G, Oza B, Sidhwani S, Gowhari M, Vara S, Gao W, Krauz L, Lavelle D, DeSimone J, Molokie R, Saunthararajah Y. Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease. Br J Haematol 153:386-392, 2011.


Sarkar S, Bustard BL, Welter JF, Baskaran H. Combined experimental and mathematical approach for development of microfabrication-based cancer migration assay. Ann Biomed Eng 39:2346-2359, 2011. PMCID: PMC3165198


Savarin C, Stohlman SA, Rietsch AM, Butchi N, Ransohoff RM, Bergmann CC. MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. Glia 59:1770-1781, 2011. PMCID: PMC3174277


Schelman WR, Liu G, Wilding G, Morris T, Phung D, Dreicer R. A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer. Invest New Drugs 29:118-125, 2011. PMCID: PMC3008512


Schirbel A, Fiocchi C. Targeting the innate immune system in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 5:33-41, 2011.


Schnell AH, Sun X, Igo RP Jr, Elston RC. Some capabilities for model-based and model-free linkage analysis using the program package S.A.G.E. (Statistical Analysis for Genetic Epidemiology). Hum Hered 72:237-246, 2011.


Schöffski P, Garcia JA, Stadler WM, Gil T, Jonasch E, Tagawa ST, Smitt M, Yang X, Oliner KS, Anderson A, Zhu M, Kabbinavar F. A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma. BJU Int 108:679-686, 2011.


Schwandt A, Chen WC, Martra F, Zola P, Debernardo R, Kunos CA. Chemotherapy plus radiation in advanced-stage endometrial cancer. Int J Gynecol Cancer 21:1622-1627, 2011.


Schwandt A, Garcia JAElson P, Wyckhouse J, Finke JH, Ireland J, Triozzi P, Zhou M, Dreicer RRini BI. Clinical and immunomodulatory effects of celecoxib plus interferon-alpha in metastatic renal cell carcinoma patients with COX-2 tumor immunostaining. J Clin Immunol 31:690-698, 2011.


Scott A, Wang Z. Tumour suppressor function of protein tyrosine phosphatase receptor-T. Biosci Rep 31:303-307, 2011. PMCID: PMC3116232


Scott JG, Suh JH , Elson PBarnett GHVogelbaum MAPeereboom DM, Stevens GH, Elinzano H, Chao ST . Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol 13:428-436, 2011. PMCID: PMC3064699


Sears N, Sen GCStark GR, Chattopadhyay S. Caspase-8-mediated cleavage inhibits IRF-3 by facilitating its proteasome-mediated degradation. J Biol Chem 286:33037-33044, 2011. PMCID: PMC3190878


Seiberlich N, Ehses P, Duerk J, Gilkeson R, Griswold M. Improved radial GRAPPA calibration for real-time free-breathing cardiac imaging. Magn Reson Med 65:492-505, 2011. PMCID: PMC3012142


Seiberlich N, Lee G, Ehses P, Duerk JL, Gilkeson R, Griswold M. Improved temporal resolution in cardiac imaging using through-time spiral GRAPPA. Magn Reson Med 66:1682-1688, 2011. PMCID: PMC3247784


Sekeres MA, Gundacker H, Lancet J, Advani A, Petersdorf S, Liesveld J, Mulford D, Norwood T, Willman CL, Appelbaum FR, List AF. A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group study S0605. Blood 118:523-528, 2011. PMCID: PMC3142897


Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D. Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. Cancer 117:992-1000, 2011.


Sekeres MAMaciejewski JP, Erba HP, Afable M, Englehaupt R, Sobecks RAdvani A, Seel S, Chan J, Kalaycio ME. A phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia. Cancer 117:1253-1261, 2011.


Sekeres MAMaciejewski JP, List AF, Steensma DP, Artz A, Swern AS, Scribner P, Huber J, Stone R. Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey. Oncologist 16:904-911, 2011.


Sekeres MA, O'Keefe C, List AF, Paulic K, Afable M 2nd, Englehaupt R, Maciejewski JP. Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes. Am J Hematol 86:102-103, 2011.


Sekeres MA, Steensma DP. A piece of my mind. The road warriors. JAMA 306:805-806, 2011.


Sekeres MA. Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010. J Natl Compr Canc Netw 9:57-63, 2011.


Sekeres MA. If Nostradamus were treated for MDS. Blood 117:374-375, 2011. PMID: 21233319


Sekeres MA. Lenalidomide in MDS: 4th time's a charm. Blood 118:3757-3758, 2011.


Sekeres MA. Second thoughts from Sekeres: on (cology) language. Oncol Times 33:16, 2011.


Sekeres MA. The avastin story. N Engl J Med 365:1454-1455, 2011. PMID: 21995408


Sekeres MA. The baby whisperer. J Clin Oncol 29:4584-4585, 2011.


Sekeres MA. Tricking or treating myelodysplastic syndromes. Oncology (Williston Park) 25:488, 490, 492, 2011.


Sellar R, Goldstone AH, Lazarus HM. Redefining transplant in acute leukemia. Curr Treat Options Oncol 12:312-328, 2011.


Serio B, Selleri C, Maciejewski JP. Impact of immunogenetic polymorphisms in bone marrow failure syndromes. Mini Rev Med Chem 11:544-552, 2011


Setoguchi K, Schenk AD, Ishii D, Hattori Y, Baldwin WM 3rd, Tanabe K, Fairchild RL. LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am J Transplant 11:923-935, 2011. PMCID: PMC3215941


Seyidova-Khoshknabi D, Davis MP, Walsh D. Review article: a systematic review of cancer-related fatigue measurement questionnaires. Am J Hosp Palliat Care 28:119-129, 2011.


Shah T, Lu L, Dell KM, Pagel MD, Griswold MA, Flask CA. CEST-FISP: a novel technique for rapid chemical exchange saturation transfer MRI at 7 T. Magn Reson Med 65:432-437, 2011.


Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, Wang KK, Fleischer DE, Sharma VK, Eisen GM, Fennerty MB, Hunter JG, …et al, Sharma P, Chak A, Lightdale CJ. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 141:460-468, 2011. PMCID: PMC3152658


Sharma A, Lou H. Depolarization-mediated regulation of alternative splicing. Front Neurosci 5:141, 2011. PMCID: PMC3246316


Sharma NK, Silverman JS, Li T, Cheng J, Yu JQ, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman GM, Konski AA. Decreased posttreatment SUV on PET scan is associated with improved local control in medically inoperable esophageal cancer. Gastrointest Cancer Res 4:84-89, 2011. PMCID: PMC3201642


Sharp RR, Goldlust ME, Eng C. Addressing gaps in physician education using personal genomic testing. Genet Med 13:750-751, 2011.


Shats I, Gatza ML, Chang JT, Mori S, Wang J, Rich J, Nevins JR. Using a stem cell-based signature to guide therapeutic selection in cancer. Cancer Res 71:1772-1780, 2011. PMCID: PMC3049992


Shen J, Liu X, Yu WM, Liu J, Groot Nibbelink M, Guo C, Finkel T, Qu CK. A critical role of mitochondrial phosphatase Ptpmt1 in embryogenesis reveals a mitochondrial metabolic stress-induced differentiation checkpoint in embryonic stem cells. Mol Cell Biol 31:4902-4916, 2011. PMCID: PMC3233018


Shen X, Denittis A, Werner-Wasik M, Axelrod R, Gilman P, Meyer T, Treat J, Curran WJ, Machtay M. Phase I study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma. Radiat Oncol 6:17, 2011. PMCID: PMC3050732


Shenoy C, Klem I, Crowley AL, Patel MR, Winchester MA, Owusu C, Kimmick GG. Cardiovascular complications of breast cancer therapy in older adults. Oncologist 16:1138-1143, 2011.


Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH, Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R; The Gliogene Consortium, Melin BS, Bondy ML. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res 71:7568-7575, 2011. PMCID: PMC3242820


Shi W, Chance MR. Metalloproteomics: forward and reverse approaches in metalloprotein structural and functional characterization. Curr Opin Chem Biol 15:144-148, 2011. PMCID: PMC3040278


Shi W, Punta M, Bohon J, Sauder JM, D'Mello R, Sullivan M, Toomey J, Abel D, Lippi M, Passerini A, Frasconi P, Burley SK, Rost B, Chance MR. Characterization of metalloproteins by high-throughput X-ray absorption spectroscopy. Genome Res 21:898-907, 2011. PMCID: PMC3106322


Shi X, Liu X, Wu X, Lu ZR, Li SK, Jeong EK. Ocular pharmacokinetic study using t(1) mapping and gd-chelate- labeled polymers. Pharm Res 28:3180-3188, 2011. PMCID: PMC3230720


Shinohara K, Greenfield S, Pan H, Vasanji A, Kumagai K, Midura RJ, Kiedrowski M, Penn MS, Muschler GF. Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res 29:1064-1069, 2011.


Shukla GC, Haque F, Tor Y, Wilhelmsson LM, Toulmé JJ, Isambert H, Guo P, Rossi JJ, Tenenbaum SA, Shapiro BA. A boost for the emerging field of RNA nanotechnology. ACS Nano 5:3405-3418, 2011. PMCID: PMC3102291


Sicheri F, Silverman RH. Putting the brakes on the unfolded protein response. J Cell Biol 193:17-19, 2011. PMCID: PMC3082173


Sikand K, Shukla GC. Functionally important structural elements of U12 snRNA. Nucleic Acids Res 39:8531-8543, 2011. PMCID: PMC3201867


Sikand K, Slaibi JE, Singh R, Slane SD, Shukla GC. miR 488* inhibits androgen receptor expression in prostate carcinoma cells. Int J Cancer 129:810-819, 2011.


Siminoff LA, Step MM. A comprehensive observational coding scheme for analyzing instrumental, affective, and relational communication in health care contexts. J Health Commun 16:178-197, 2011. PMCID: PMC3147015


Simmons MN, Fergany AF, Campbell SC . Effect of parenchymal volume preservation on kidney function after partial nephrectomy. J Urol 186:405-410, 2011.


Simon DI. Opening the field of integrin biology to "biased agonism". Circ Res 109:1199-1201, 2011.


Singer NGCaplan AI . Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6:457-478, 2011.


Singhania R, Sramkoski RM, Jacobberger JW, Tyson JJ. A hybrid model of Mammalian cell cycle regulation. PLoS Comput Biol 7:e1001077, 2011. PMCID: PMC3037389


Siomin V, Lin JL, Marko NF, Barnett GH, Toms SA, Chao ST , Angelov L, Vogelbaum MA, Navaratne K, Suh JH , Weil RJ. Stereotactic radiosurgical treatment of brain metastases to the choroid plexus. Int J Radiat Oncol Biol Phys 80:1134-1142, 2011.


Siroy AE, Maclennan GT. Primary melanoma of the bladder. J Urol 185:1096-1097, 2011.


Siskin GP, Haskal ZJ, McLennan G, Dake MD, Haacke EM, McDonald S, Royal W 3rd, Vedantham S, Hubbard D, Sclafani SJ, Andrews RT, Sauder H. Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 22:587-593, 2011.


Skaznik-Wikiel ME, Ueda SM, Frasure HE, Rose PG, Fleury A, Grumbine FC, Fader AN. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype? Acta Cytol 55:255-260, 2011.


Sloan AE. Surgery for glioblastoma multiforme. J Neurosurg 114:585-586, 2011.


Smith AK, Stephenson AJ J, Lane BR, Larson BT, Thomas AA, Gong MC, Jones JS, Campbell SC , Hansel DE. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 78:82-86, 2011.


Smith KM, Ketchart W, Zhou X, Montano MMXu Y. Determination of hexamethylene bisacetamide, an antineoplastic compound, in mouse and human plasma by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 879:2206-2212, 2011.


Smith MR, Neuberg D, Flinn IW, Grever MR, Lazarus HM, Rowe JM, Dewald G, Bennett JM, Paietta EM, Byrd JC, Hussein MA, Appelbaum FR, Larson RA, Litzow MR, Tallman MS. Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. Blood 118:3525-3527, 2011. PMCID: PMC3186330


Smith SD, Bolwell BJ, Rybicki LA, Kang T, Dean RAdvani A, Thakkar S, Sobecks RKalaycio MPohlman BSweetenham JW. Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab. Bone Marrow Transplant 46:262-266, 2011.


Smith SD, Moskowitz CH, Dean RPohlman BSobecks RCopelan E, Andresen S, Bolwell B, Maragulia JC, Vanak JM, Sweetenham J, Moskowitz AJ. Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres. Br J Haematol 153:358-363, 2011.


Sobecks RM, Askar M, Thomas D, Rybicki L, Kalaycio MDean R, Avery R, Mossad S, Copelan EBolwell BJ. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype. Exp Clin Transplant 9:7-13, 2011. PMID: 21605017


Sobecks RM, Copelan EKalaycio M, Askar M, Rybicki L, Serafino S, Serafin M, Macklis RDean RPohlman B, Andresen S, Bolwell BJ. Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients. Br J Haematol 152:116-119, 2011.


Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood 117:6963-6970, 2011. PMCID: PMC3128486


Soldatova AV, Kim J, Rizzoli C, Kenney ME, Rodgers MA, Rosa A, Ricciardi G. Near-infrared-emitting phthalocyanines. A combined experimental and density functional theory study of the structural, optical, and photophysical properties of Pd(II) and Pt(II) α-butoxyphthalocyanines. Inorg Chem 50:1135-1149, 2011.


Somanath PR, Podrez EA, Chen J, Ma Y, Marchant K, Antoch M, Byzova TV. Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype. J Cell Physiol 226:132-140, 2011. PMCID: PMC2982145


Soriano A, Davis MP. Malignant bowel obstruction: individualized treatment near the end of life. Cleve Clin J Med 78:197-206, 2011. PMID: 21364165


Sorrell JM, Baber MA, Traktuev DO, March KL, Caplan AI . The creation of an in vitro adipose tissue that contains a vascular-adipocyte complex. Biomaterials 32:9667-9676, 2011.


Sos BC, Harris C, Nordstrom SM, Tran JL, Balázs M, Caplazi P, Febbraio M, Applegate MA, Wagner KU, Weiss EJ Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. J Clin Invest 121:1412–1423, 2011. PMCID: PMC3069761


Sossey-Alaoui K, Downs-Kelly E, Das M, Izem L, Tubbs R, Plow EF. WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. Int J Cancer 129:1331-1343, 2011. PMCID: PMC3081370


Sperduto PW, Chao ST , Suh J, Sneed PK, Luo X, Roberge D, Bhatt A, Mehta MP, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM. Reply to Drs. Mulvenna and Holt [Response to “Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.” (Int J Radiat Oncol Biol Phys 2010:77:655-661)]. Int J Radiat Oncol Biol Phys 81:1194-1195, 2011.


Spires J, Lai N, Zhou H, Saidel GM. Hemoglobin and myoglobin contributions to skeletal muscle oxygenation in response to exercise. Adv Exp Med Biol 915:347-352, 2011.


Sprague BL, Thompson CL, Ganz PA, Kanetsky PA, Kushi LH, Nebeling L. The business of research: budgets, personnel, planning, and pitfalls--a report from the American Society of Preventive Oncology's Junior Members Interest Group. Cancer Epidemiol Biomarkers Prev 20:1802-1804, 2011.


Sproat L, Bolwell B, Rybicki L, Dean RSobecks RPohlman B, Andresen S, Sweetenham JCopelan EKalaycio M. Vitamin D level after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 17:1079-1083, 2011.


Stange KC. In this issue: clinical decision support. Ann Fam Med 9:2, 2011. PMCID: PMC3022038


Stange KC. Refocusing knowledge generation, application, and education raising our gaze to promote health across boundaries. Am J Prev Med 41(4 Suppl 3):S164-S169, 2011.


Staquicini FI, Ozawa MG, Moya CA, Driessen WH, Barbu EM, Nishimori H, Soghomonyan S, Flores LG 2nd, Liang X, Paolillo V, Alauddin MM, Basilion JP, Furnari FB, Bogler O, Lang FF, Aldape KD, Fuller GN, Höök M, Gelovani JG, Sidman RL, Cavenee WK, Pasqualini R, Arap W. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest 121:161-173, 2011. PMCID: PMC3007161


Stark GR, Wang Y, Lu T. Lysine methylation of promoter-bound transcription factors and relevance to cancer. Cell Res 21:375-380, 2011. PMCID: PMC3193425


Stefan T, Jacobberger JW. Laser scanning cytometry of mitosis: state and stage analysis. Methods Cell Biol 102:341-372, 2011.


Stefflova K, Dulik MC, Barnholtz-Sloan JS , Pai AA, Walker AH, Rebbeck TR. Dissecting the within-Africa ancestry of populations of African descent in the Americas. PLoS One 6:e14495, 2011. PMCID: PMC3017210


Stein BL, Williams DM, O'Keefe C, Rogers O, Ingersoll RG, Spivak JL, Verma A, Maciejewski JP, McDevitt MA, Moliterno AR. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. Haematologica 96:1462-1469, 2011. PMCID: PMC3186307


Steinmetz NF, Ablack AL, Hickey JL, Ablack J, Manocha B, Mymryk JS, Luyt LG, Lewis JD. Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing peptide receptors. Small 7:1664-1672, 2011. PMCID: PMC3163449


Steinmetz NF, Cho CF, Ablack A, Lewis JD, Manchester M. Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. Nanomedicine (Lond) 6:351-364, 2011.


Step MM, Ray EB. Patient perceptions of oncologist-patient communication about prognosis: changes from initial diagnosis to cancer recurrence. Health Commun 26:48-58, 2011.


Stephani C, Fernandez-Baca Vaca G, Maciunas R, Koubeissi M, Lüders HO. Functional neuroanatomy of the insular lobe. Brain Struct Funct 216:137-149, 2011. PMCID: PMC3097350


Stephans K, Khouri A, Machtay M. The role of PET in the evaluation, treatment, and ongoing management of lung cancer. PET Clin 6:177-184, 2011.


Stephenson AJ, Aprikian AG, Gilligan TD, Oldenburg J, Powles T, Toner GC, Bedford Waters W. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD consensus meeting on germ cell tumors (GCT), Shanghai 2009. Urology 78(4 Suppl):S444-S455, 2011.


Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, Bridger G, Marulkar S, Hsu FJ, Dipersio JF. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin's lymphoma or multiple myeloma. Biol Blood Marrow Transplant 17:1146-1153, 2011.


Stone JG, Siedlak SL, Tabaton M, Hirano A, Castellani RJ, Santocanale C, Perry G, Smith MAZhu X, Lee HG. The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies. J Neuropathol Exp Neurol 70:578-587, 2011. PMCID: PMC3122485


Stovsky M, Ponsky L, Vourganti S, Stuhldreher P, Siroky MB, Kipnis V, Fedotoff O, Mikheeva L, Zaslavsky B, Chait A, Jones JS. Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples. Urology 78:601-605, 2011. PMCID: PMC3166363


Straus DJ, Johnson JL, LaCasce AS, Bartlett NL, Kostakoglu L, Hsi ED, Schöder H, Hall NC, Jung SH, Canellos GP, Schwartz LH, Takvorian RW, Juweid ME, Cheson BD; Cancer and Leukemia Group B. Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood 117:5314-5320, 2011. PMCID: PMC3109706


Stuhldreher PP, Ponsky LEMaclennan GT. Melanosis of the bladder. J Urol 185:1908-1909, 2011.


Su Y, Ospina JK, Zhang J, Michelson AP, Schoen AM, Zhu AJ. Sequential phosphorylation of smoothened transduces graded hedgehog signaling. Sci Signal 4:ra43, 2011.


Sucheston LE, Zhao H, Yao S, Zirpoli G, Liu S, Barlow WE, Moore HCBudd GT, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Livingston RB, Albain KS, Hayes DF, Ambrosone CB. Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Res Treat 130:993-1002, 2011.


Sukhdeo K, Hambardzumyan DRich JN. Glioma development: where did it all go wrong? Cell 146:187-188, 2011.


Sullivan M, Rybicki LA, Winter A, Hoffmann MM, Reiermann S, Linke H, Arbeiter K, Patzer L, Budde K, Hoppe B, Zeier M, Lhotta K, Bock A, Wiech T, Gaspert A, Fehr T, Woznowski M, Berisha G, Malinoc A, Goek ON, Eng C, Neumann HP. Age-related penetrance of hereditary atypical hemolytic uremic syndrome. Ann Hum Genet 75:639-647, 2011.


Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M. Delivering affordable cancer care in high-income countries. Lancet Oncol 12:933-980, 2011.


Summers P, Bena J, Arrigain S, Alexis AF, Cooper KBordeaux JS. Sunscreen use: non-Hispanic blacks compared with other racial and/or ethnic groups. Arch Dermatol 147:863-864, 2011.


Sun D, Novotny M, Bulek K, Liu C, Li XHamilton T. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol 12:853-860, 2011.


Sun J, Zborowski M, Chalmers JJ. Quantification of both the presence, and oxidation state, of Mn in Bacillus atrophaeus spores and its imparting of magnetic susceptibility to the spores. Biotechnol Bioeng 108:1119-1129, 2011.


Sun S, Chen Z, Yan PS, Huang YW, Huang TH, Lin S. Identifying hypermethylated CpG islands using a quantile regression model. BMC Bioinformatics 12:54, 2011. PMCID: PMC3051900


Sun S, Huang YW, Yan PS, Huang TH, Lin S. Preprocessing differential methylation hybridization microarray data. BioData Min 4:13, 2011. PMCID: PMC3118966


Sun Y, Perera J, Rubin BP, Huang J. SYT-SSX1 (Synovial Sarcoma Translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein. J Biol Chem 286:18623-18632, 2011. PMCID: PMC3099678


Suzuki N, Guagliumi G, Bezerra HG, Sirbu V, Rosenthal N, Musumeci G, Aprile A, Wang H, Kyono H, Tahara S, Simon DIRollins A, Costa MA. The impact of an eccentric intravascular ImageWire during coronary optical coherence tomography imaging. EuroIntervention 6:963-969, 2011.


Swanson GP, Yu C, Kattan MW, Hermans MR. Validation of postoperative nomograms in prostate cancer patients with long-term follow-up. Urology 78:105-109, 2011.


Sweetenham JW, Freedman AS. Early initial therapy of advanced follicular lymphoma: the need for vigilance. Leuk Lymphoma 52:355-357, 2011.


Sweetenham JW, Polliack A. Progressive transformation of germinal centers and Hodgkin lymphoma – more insights but maybe more confusion? Leuk Lymphoma 52:2041-2042, 2011.


Sweetenham JW. "Pet negativity"–the new goal of cytoreductive therapy in Hodgkin's lymphoma? Biol Blood Marrow Transplant 17:1569-1570, 2011.


Sweetenham JW. Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma. Curr Opin Hematol 18:288-292, 2011.

Tamblyn DJ, Chopra S, Yu C, Kattan MW, Pinnock C, Kopsaftis T. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. BJU Int 108(Suppl 2):51-56, 2011.


Tan M, Lu ZR. Integrin targeted MR imaging. Theranostics 1:83-101, 2011. PMCID: PMC3086609


Tan M, Ye Z, Jeong EK, Wu X, Parker DL, Lu ZR. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents. Bioconjug Chem 22:931-937, 2011.


Tan MH, Eng C. Testicular microlithiasis: recent advances in understanding and management. Nat Rev Urol 8:153-163, 2011.


Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS, Eng C. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 88:42-56, 2011. PMCID: PMC3014373


Tan N, Klein EA , Li J, Moussa AS, Stephen Jones J. Statin use and risk of prostate cancer in a population of men who underwent biopsy. J Urol 186:86-90, 2011.


Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, Mitsopoulos C, Zvelebil M, Hoch BL, Weiss SW, Debiec-Rychter M, Sciot R, West RB, Lazar AJ, Ashworth A, Reis-Filho JS, Lord CJ, Gerstein MB, Rubin MA, Rubin BP. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 3:98ra82, 2011.


Tang X, Sayre LM, Tochtrop GP. A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c. J Mass Spectrom 46:290-297, 2011.


Tarn DM, Flocke SA . New prescriptions: how well do patients remember important information? Fam Med 43:254-259, 2011. PMCID: PMC3099139


Taylor DJ, Podell ER, Taatjes DJ, Cech TR. Multiple POT1-TPP1 proteins coat and compact long telomeric single-stranded DNA. J Mol Biol 410:10-17, 2011. PMCID: PMC3157753


Taylor MA, Amin JD, Kirschmann DA, Schiemann WP. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells. Neoplasia 13:406-418, 2011. PMCID: PMC3084617


Taylor MA, Lee YH, Schiemann WP. Role of TGF-beta and the tumor microenvironment during mammary tumorigenesis. Gene Expr 15:117-132, 2011.


Thatiparti TR, Averell N, Overstreet D, von Recum HA. Multiplexing interactions to control antibiotic release from cyclodextrin hydrogels. Macromol Biosci 11:1544-1552, 2011.


Thomas AA, Campbell SC . Small renal masses: toward more rational treatment. Cleve Clin J Med 78:539-547, 2011. PMID: 21807926


Thomas AA, Demirjian S, Lane BR, Simmons MN, Goldfarb DA, Subramanian VS, Campbell SC . Acute kidney injury: novel biomarkers and potential utility for patient care in urology. Urology 77:5-11, 2011.


Thompson CL, Larkin EK, Patel SBerger NA, Redline S, Li L. Short duration of sleep increases risk of colorectal adenoma. Cancer 117:841-847, 2011. PMCID: PMC3021092


Tian M, Neil JR, Schiemann WP. Transforming growth factor-β and the hallmarks of cancer. Cell Signal 23:951-962, 2011. PMCID: PMC3076078


Tirotta E, Ransohoff RM, Lane TE. CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-γ/CXCL10-mediated apoptosis. Glia 59:1518-1528, 2011.


Tiu RV, Gondek LP, O'Keefe CL, Elson P, Huh J, Mohamedali A, Kulasekararaj A, Advani AS, Paquette R, List AF, Sekeres MA, McDevitt MA, Mufti GJ,Maciejewski JP. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Blood 117:4552-4560, 2011. PMCID: PMC3099573


Tiu RVSekeres MA. Lenalidomide in del 5q MDS: responses and side effects revisited. Leuk Res 35:1440-1441, 2011.


Tiu RV, Traina F, Sekeres MA. Clofarabine for myelodysplastic syndromes. Expert Opin Investig Drugs 20:1005-1014, 2011.


Tiu RV, Visconte V, Traina F, Schwandt A, Maciejewski JP. Updates in cytogenetics and molecular markers in MDS. Curr Hematol Malig Rep 6:126-135, 2011.


Tobi M, Kim M, Zimmer R, Hatfield J, Kam M, Khoury N, Carville A, Lawson MJ, Schiemann WP, Thomas P. Colorectal cancer in the cotton top tamarin (Saguinus oedipus): how do they evade liver metastasis? Dig Dis Sci 56:397-405, 2011.


Tomcik K, Ibarra RA, Sadhukhan S, Han Y, Tochtrop GP, Zhang GF. Isotopomer enrichment assay for very short chain fatty acids and its metabolic applications. Anal Biochem 410:110-117, 2011. PMCID: PMC3055175


Tong GX, Memeo L, Colarossi C, Hamele-Bena D, Magi-Galluzzi C, Zhou M, Lagana SM, Harik L, Oliver-Krasinski JM, Mansukhani M, Falcone L, Hibshoosh H, O'Toole K. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract. Am J Surg Pathol 35:1473-1483, 2011.


Torres V, Triozzi PEng C, Tubbs R, Schoenfiled L, Crabb JW, Saunthararajah Y, Singh AD. Circulating tumor cells in uveal melanoma. Future Oncol 7:101-109, 2011.


Toy R, Hayden E, Shoup C, Baskaran H, Karathanasis E. The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology 22:115101, 2011.


Tran VA, Johnson N, Redline S, Zhang GQ. OnWARD: ontology-driven web-based framework for multi-center clinical studies. J Biomed Inform 44(Suppl 1):S48-S53, 2011. PMCID: PMC3251701


Trask PC, Bushmakin AG, Cappelleri JC, Tarazi J, Rosbrook B, Bycott P, Kim S, Stadler WM, Rini B. Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma. J Cancer Surviv 5:255-262, 2011.


Traudt K, Ciezki JKlein EA . Low-dose-rate brachytherapy as salvage treatment of local prostate cancer recurrence after radical prostatectomy. Urology 77:1416-1419, 2011.


Triozzi PL, Aldrich W, Ponnazhagan S. Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists. Cancer Gene Ther 18:850-858, 2011.


Triozzi PL, Aldrich W, Singh A. Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma. Invest Ophthalmol Vis Sci 52:5529-5535, 2011. PMCID: PMC3176055


Triozzi PLBorden EC. VB-111 for cancer. Expert Opin Biol Ther 11:1669-1676, 2011.


Triozzi PL, Singh AD. Blood biomarkers of uveal melanoma metastasis. Br J Ophthalmol 95:3-4, 2011.


Triozzi PL, Tuthill RJ, Borden E. Re-inventing intratumoral immunotherapy for melanoma. Immunotherapy 3:653-671, 2011.


Trunzo JA, McGee MF, Poulose BK, Willis JE, Ermlich B, Laughinghouse M, Champagne BJ, Delaney CP, Marks JM. A feasibility and dosimetric evaluation of endoscopic radiofrequency ablation for human colonic and rectal epithelium in a treat and resect trial. Surg Endosc 25:491-496, 2011.


Tun-Kyi A, Finn G, Greenwood A, Nowak M, Lee TH, Asara JM, Tsokos GC, Fitzgerald K, Israel E, Li X, Exley M, Nicholson LK, Lu KP. Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat Immunol 12:733-741, 2011.


Tuohy VK, Jaini R. Prophylactic cancer vaccination by targeting functional non-self. Ann Med 43:356-365, 2011. PMCID: PMC3203523

Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringdén O, Weisdorf DJ, Rizzo JD. Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. Bone Marrow Transplant 46:34-43, 2011. PMCID: PMC3169009

Valadkhan S. A snRNP's ordered path to maturity. Genes Dev 25:1563-1567, 2011. PMCID: PMC3182023


van den Bent M, Wefel J, Schiff D, Taphoorn M, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman A, Gorlia T, Chamberlain M, Baumert B,Vogelbaum M, Macdonald D, Reardon D, Wen P, Chang S, Jacobs A. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583-593, 2011.


van Heeckeren WJ, Fu P, Barr PM, Arfons LM, Kirschbaum MH, Lazarus HMCooper BW. Safety and tolerability of phase I/II clinical trials among older and younger patients with acute myelogenous leukemia. J Geriatr Oncol 2:215-221, 2011.


van Panhuys N, Prout M, Forbes E, Min B, Paul WE, Le Gros G. Basophils are the major producers of IL-4 during primary helminth infection. J Immunol 186:2719-2728, 2011.


VanAntwerp AE, Raymond SM, Addington MC, Gajdos S, Vassil A, Xia P. Dosimetric evaluation between megavoltage cone-beam computed tomography and body mass index for intracranial, thoracic, and pelvic localization. Med Dosim 36:284-291, 2011.


Venere M, Fine HA, Dirks PB, Rich JN. Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia 59:1148-1154, 2011. PMCID: PMC3107874


Vernon LT, Babineau DC, Demko CA, Lederman MM, Wang X, Toossi Z, Weinberg A, Rodriguez B. A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults. AIDS Res Hum Retroviruses 27:1157-1166, 2011. PMCID: PMC3206743


Vickers AJ, Savage CJ, Bianco FJ, Klein EA , Kattan MW, Secin FP, Guilloneau BD, Scardino PT. Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience. Int J Cancer 128:1697-1702, 2011. PMCID: PMC2970654


Visioni A, Kim J. Positron emission tomography for benign and malignant disease. Surg Clin North Am 91:249-266, 2011. PMCID: PMC3021752


Vogl DT, Wang T, Pérez WS, Stadtmauer EA, Heitjan DF, Lazarus HM, Kyle RA, Kamble R, Weisdorf D, Roy V, Gibson J, Ballen K, Holmberg L, Bashey A, McCarthy PL, Freytes C, Maharaj D, Maiolino A, Vesole D, Hari P. Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 17:1765-1774, 2011. PMCID: PMC3175301


von Bueren AO, Oehler C, Shalaby T, von Hoff K, Pruschy M, Seifert B, Gerber NU, Warmuth-Metz M, Stearns D, Eberhart CG, Kortmann RD, Rutkowski S, Grotzer MA. c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer 11:74, 2011. PMCID: PMC3050852


von Dücker L, Walz MK, Voss C, Arnold G, Eng C, Neumann HP. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. World J Surg 35:563-567, 2011.


von Gruenigen VE, Frasure HE, Kavanagh MB, Lerner E, Waggoner SE, Courneya KS. Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecol Oncol 122:328-333, 2011.


von Gruenigen VE, Waggoner SE, Frasure HE, Kavanagh MB, Janata JW, Rose PG, Courneya KS, Lerner E. Lifestyle challenges in endometrial cancer survivorship. Obstet Gynecol 117:93-100, 2011.


Vricella GJ, Haaga JR, Adler BL, Nakamoto D, Cherullo EE, Flick S, Ponsky LE. Percutaneous cryoablation of renal masses: impact of patient selection and treatment parameters on outcomes. Urology 77:649-654, 2011.


Vykhovanets EV, Maclennan GT, Vykhovanets OV, Gupta S. IL-17 expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients. Int J Clin Exp Pathol 4:552-565, 2011. PMCID: PMC3160607


Vykhovanets EV, Shankar E, Vykhovanets OV, Shukla S, Gupta S. High-fat diet increases NF-κB signaling in the prostate of reporter mice. Prostate 71:147-156, 2011.

Wada DA, Law ME, Hsi ED, Dicaudo DJ, Ma L, Lim MS, Souza A, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol 24:596-605, 2011. PMCID: PMC3122134


Wadhera RK, Kyle RA, Larson DR, Dispenzieri A, Kumar S, Lazarus HM, Rajkumar SV. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma. Blood 118:2985-2987, 2011. PMCID: PMC3175778


Walker JM, Myers AM, Schluchter MD, Goldberg VM, Caplan AI , Berilla JA, Mansour JM, Welter JF. Nondestructive evaluation of hydrogel mechanical properties using ultrasound. Ann Biomed Eng 39:2521-2530, 2011.


Walz J, Joniau S, Chun FK, Isbarn H, Jeldres C, Yossepowitch O, Chao-Yu H, Klein EA , Scardino PT, Reuther A, Poppel HV, Graefen M, Huland H, Karakiewicz PI. Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy. BJU Int 107:765-770, 2011.


Wan Y, Kim TW, Yu M, Zhou H, Yamashita M, Kang Z, Yin W, Wang JA, Thomas J, Sen GCStark GRLi X. The dual functions of IL-1 receptor-associated kinase 2 in TLR9-mediated IFN and proinflammatory cytokine production. J Immunol 186:3006-3014, 2011. PMCID: PMC3163905


Wang AZ, Li L, Zhang B, Shen GQ, Wang QK. Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population. Ann Hum Genet 75:475-482, 2011. PMCID: PMC3115468


Wang B. Cancer cells exploit the eph-ephrin system to promote invasion and metastasis: tales of unwitting partners. Sci Signal 4:pe28, 2011.


Wang C, Wu C, Popescu DC, Zhu J, Macklin WB, Miller RHWang Y. Longitudinal near-infrared imaging of myelination. J Neurosci 31:2382-2390, 2011. PMCID: PMC3044505


Wang C, Wu C, Zhu J, Miller RHWang Y. Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination. J Med Chem 54:2331-2340, 2011. PMCID: PMC3099240


Wang D, Olman MA, Stewart J Jr, Tipps R, Huang P, Sanders PW, Toline E, Prayson RA, Lee JWeil RJ, Palmer CA, Gillespie GY, Liu WM, Pieper RO, Guan JL, Gladson CL. Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity. PLoS One 6:e19629, 2011. PMCID: PMC3094350


Wang H, Hota PK, Tong Y, Li B, Shen L, Nedyalkova L, Borthakur S, Kim S, Tempel W, Buck M, Park HW. Structural basis of Rnd1 binding to plexin Rho GTPase binding domains (RBDs). J Biol Chem 286:26093-26106, 2011. PMCID: PMC3138255


Wang H, Kang W, Zhu HMacLennan GRollins AM. Three-dimensional imaging of ureter with endoscopic optical coherence tomography. Urology 77:1254-1258, 2011. PMCID: PMC3087827


Wang J, Engle S, Zhang Y. A new in vitro system for activating the cell cycle checkpoint. Cell Cycle 10:500-506, 2011. PMCID: PMC3050501


Wang L, Chance MR. Structural mass spectrometry of proteins using hydroxyl radical based protein footprinting. Anal Chem 83:7234-7241, 2011. PMCID: PMC3184339


Wang NX, von Recum HA. Affinity-based drug delivery. Macromol Biosci 11:321-332, 2011.


Wang X, Elston RC, Zhu X. Statistical interaction in human genetics: how should we model it if we are looking for biological interaction? Nat Rev Genet 12:74, 2011.


Wang X, Lu X, Zhou G, Lou HLuo G. RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells. Biosci Rep 31:363-369, 2011.


Wang X, Ma D, Olson WC, Heston WD . In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen. Mol Cancer Ther 10:1728-1739, 2011.


Wang Y, Romigh T, He X, Tan MH, Orloff MS, Silverman RHHeston WD , Eng C. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers. Oncogene 30:4327-4338, 2011.


Wang Y, Steimle PA, Ren Y, Ross CA, Robinson DN, Egelhoff TT, Sesaki H, Iijima M. Dictyostelium huntingtin controls chemotaxis and cytokinesis through the regulation of myosin II phosphorylation. Mol Biol Cell 22:2270-2281, 2011. PMCID: PMC3128529


Watts KE, Hansel DEMacLennan GT. Clear cell sarcoma of the kidney. J Urol 185:279-280, 2011.


Weber J, Vazquez AC, Winner D, Rose JD, Wylie D, Rhea AM, Henry K, Pappas J, Wright A, Mohamed N, Gibson R, Rodriguez B, Soriano V, King K, Arts EJ, Olivo PD, Quiñones-Mateu ME. Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapy. Antimicrob Agents Chemother 55:3729-3742, 2011. PMCID: PMC3147656


Weber Lozada K, Keri RA. Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer. Biol Reprod 85:490-497, 2011. PMCID: PMC3159535


Weight CJ, Lythgoe C, Unnikrishnan R, Lane BR, Campbell SC , Fergany AF. Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy. Urology 77:1142-1146, 2011.


Weir HK, Marrett LD, Cokkinides V, Barnholtz-Sloan J, Patel P, Tai E, Jemal A, Li J, Kim J, Ekwueme DU. Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol 65(5 Suppl 1):S38-S49, 2011. PMCID: PMC3254089


Weiser MR, Gönen M, Chou JF, Kattan MW, Schrag D. Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol 29:4796-4802, 2011.


Welford SM, Giaccia AJ. Hypoxia and senescence: the impact of oxygenation on tumor suppression. Mol Cancer Res 9:538-544, 2011. PMCID: PMC3096743


Wen PY, Schiff D, Cloughesy TF, Reardon DA, Batchelor TT, Chabner BA, Flaherty K, de Groot JF, Gilbert MR, Galanis E, Chang SM, Schwartz GK,Peereboom D, Mehta MP, Yung WK, Grossman SA, Prados MD, Deangelis LM. It is time to include patients with brain tumors in phase I trials in oncology. J Clin Oncol 29:3211-3213, 2011.


Wendt MK, Molter J, Flask CASchiemann WP. In vivo dual substrate bioluminescent imaging. J Vis Exp 56:3245, 2011. PMCID: PMC3227190


Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP. Downregulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell 22:2423-2435, 2011. PMCID: PMC3135469


White CL, Chattopadhyay S, Sen GC. Phosphatidylinositol 3-kinase signaling delays Sendai virus-induced apoptosis by preventing XIAP degradation. J Virol 85:5224-5227, 2011. PMCID: PMC3126159


White RL Jr, Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ, Avisar E, Hauschild A, Egberts F,Averbook BJ, Garberoglio CA, Vetto JT, Ross MI, Chu D, Trisal V, Hoekstra H, Whitman E, Wanebo HJ, Debonis D, Vezeridis M, Chevinsky A, Kashani-Sabet M, Shyr Y, Berry L, Zhao Z, Soong SJ, Leong SP; for the Sentinel Lymph Node Working Group. Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol 18:3593-3600, 2011.


Wilkins K, Laframboise T. Losing balance: Hardy-Weinberg disequilibrium as a marker for recurrent loss-of-heterozygosity in cancer. Hum Mol Genet 20:4831-4839, 2011. PMCID: PMC3221535


Williams AS, Moore SM. Universal design of research: inclusion of persons with disabilities in mainstream biomedical studies. Sci Transl Med 3:82cm12, 2011.


Williamson SR, Zhang S, Lopez-Beltran A, Shah RB, Montironi R, Tan PH, Wang M, Baldridge LA, Maclennan GT, Cheng L. Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol 35:474-483, 2011.


Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, Osunkoya AO, Maclennan GT, Montironi R, Cheng L. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol 24:1120-1127, 2011.


Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 29:2230-2239, 2011. PMCID: PMC3107742


Witzig TE, Fishkin P, Gordon LI, Gregory SA, Jacobs S, Macklis R, McLaughlin P, Press O, Zelenetz AD. Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report. Leuk Lymphoma 52:1188-1199, 2011.


Wolkenhauer O, Shibata DK, Mesarović MD. A stem cell niche dominance theorem. BMC Syst Biol 5:4, 2011. PMCID: PMC3030540


Woods C, Sohn JW, Yao M. The application of PET in radiation treatment planning for head and neck cancer. PET Clin 6:149-163, 2011.


Woost PG, Solchaga LA, Meyerson HJ, Shankey TV, Goolsby CL, Jacobberger JW. High resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow. Blood 117:e131-e141, 2011. PMCID: PMC3087539


Wu XC, Eide MJ, King J, Saraiya M, Huang Y, Wiggins C, Barnholtz-Sloan JS , Martin N, Cokkinides V, Miller J, Patel P, Ekwueme DU, Kim J. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol 65(5 Suppl 1):S26-S37, 2011.

Xu D, Liu X, Yu WM, Meyerson HJ, Guo C, Gerson SLQu CK. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells. J Exp Med 208:1977-1988, 2011. PMCID: PMC3182060

Xu-Cai YO, Shen J, Chen S, Zhou Y, Larusch GA, Stavrou E, Schmaier AH, Wu Q. Factor XII gene mutation in the Hageman family. J Thromb Haemost 9:2329-2331, 2011. PMCID: PMC3206169

Yamaguchi Y, Simmons MN, Campbell SC . Small renal masses: risk prediction and contemporary management. Hematol Oncol Clin North Am 25:717-736, 2011. Yan H, Choi AJ, Lee BH, Ting AH. Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells. PLoS One 6:e20628, 2011. PMCID: PMC3116843


Yang GB, Barnholtz-Sloan JS , Chen Y, Bordeaux JS. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer. Arch Dermatol 147:1395-1402, 2011.


Yang H, Kim C, Kim MJ, Schwendener RA, Alitalo K, Heston W, Kim I, Kim WJ, Koh GY. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol Cancer 10:36, 2011. PMCID: PMC3080348


Yang S, Roux B. EROS: better than SAXS! Structure 19:3-4, 2011.


Yang Y, Lewis R, Miller RH. Interactions between oligodendrocyte precursors control the onset of CNS myelination. Dev Biol 350:127-138, 2011. PMCID: PMC3032606


Yang Y, Samas B, Kennedy VO, Macikenas D, Chaloux BL, Miller JA, Speer RL, Protasiewicz J, Pinkerton AA, Kenney ME. Long, directional interactions in cofacial silicon phthalocyanine oligomers. J Phys Chem A 115:12474-12485, 2011.


Yao D, Huang Y, Huang X, Wang W, Yan Q, Wei L, Xin WGerson S, Stanley P, Lowe JB, Zhou L. Protein O-fucosyltransferase 1 (Pofut1) regulates lymphoid and myeloid homeostasis through modulation of Notch receptor ligand interactions. Blood 117:5652-5662, 2011. PMCID: PMC3110024


Yarmohammadi H, Nakamoto DA, Azar N, Hayek SM, Haaga JR. Percutaneous computed tomography guided cryoablation of the celiac plexus as an alternative treatment for intractable pain caused by pancreatic cancer. J Cancer Res Ther 7:481-483, 2011. PMID: 22269414


Yazbek SN, Buchner DA, Geisinger JM, Burrage LC, Spiezio SH, Zentner GE, Hsieh CW, Scacheri PC, Croniger CM, Nadeau JH. Deep congenic analysis identifies many strong, context-dependent QTLs, one of which, Slc35b4, regulates obesity and glucose homeostasis. Genome Res 21:1065-1073, 2011. PMCID: PMC3129249


Ye C, Cui Y, Wei C, Elston RC, Zhu J, Lu Q. A non-parametric method for building predictive genetic tests on high-dimensional data. Hum Hered 71:161-170, 2011.


Ye F, Lemieux H, Hoppel CLHanson RW, Hakimi P, Croniger CM, Puchowicz M, Anderson VE, Fujioka H, Stavnezer E. Peroxisome proliferator-activated receptor γ (PPARγ) mediates a Ski oncogene-induced shift from glycolysis to oxidative energy metabolism. J Biol Chem 286:40013-40024, 2011. PMCID: PMC3220574


Yi TElson P, Mitsuhashi M, Jacobs B, Hollovary E, Budd GT, Spiro T, Triozzi PBorden EC. Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects. Oncotarget 2:1155-1164, 2011.


Yildiz I, Shukla S, Steinmetz NF. Applications of viral nanoparticles in medicine. Curr Opin Biotechnol 22:901-908, 2011. PMCID: PMC3206135


Yin L, Rao P, Elson P, Wang J, Ittmann M, Heston WD . Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression. PLoS One 6:e21319, 2011. PMCID: PMC3123299


Yin W, Wan Y, Kim TW, Yao P, Xiao H, Zhou H, Xiao J, Fox PLi X. The kinase activity of interleukin-1 receptor-associated kinase 2 is essential for lipopolysaccharide-mediated cytokine and chemokine mRNA stability and translation. J Interferon Cytokine Res 31:415-422, 2011. PMCID: PMC3083721


Yohannes E, Ghosh SK, Jiang B, McCormick TS, Weinberg A, Hill E, Faddoul F, Chance MR. Proteomic signatures of human oral epithelial cells in HIV-infected subjects. PLoS One 6:e27816, 2011. PMCID: PMC3218055


Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, Schiemann WPKeri RA. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 13:601-610, 2011. PMCID: PMC3132846


Yu S, Zhang Y, Yuen MT, Zou C, Danielpour D, Chan FL. 17-beta-estradiol induces neoplastic transformation in prostatic epithelial cells. Cancer Lett 304:8-20, 2011.


Yuan Y, Cao P, Smith MA, Kramp K, Huang Y, Hisamoto N, Matsumoto K, Hatzoglou M, Jin H, Feng Z. Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PLoS One 6:e22354, 2011. PMCID: PMC3153934


Yutzy SR, Seiberlich N, Duerk JL, Griswold MA. Improvements in multislice parallel imaging using radial CAIPIRINHA. Magn Reson Med 65:1630-1637, 2011. PMCID: PMC3097277

Zaytoun OM, Kattan MW, Moussa AS, Li J, Yu C, Jones JS. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information. Urology 78:392-398, 2011.


Zborowski M, Chalmers JJ. Rare cell separation and analysis by magnetic sorting. Anal Chem 83:8050-8056, 2011. PMCID: PMC3205221


Zechel JL, Maclennan GT, Heaney JD, Nadeau JH. Spontaneous metastasis in mouse models of testicular germ-cell tumours. Int J Androl 34:e278-e287, 2011.


Zentner GE, Saiakhova A, Manaenkov P, Adams MDScacheri PC. Integrative genomic analysis of human ribosomal DNA. Nucleic Acids Res 39:4949-4960, 2011. PMCID: PMC3130253


Zentner GE, Tesar PJScacheri PC. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res 21:1273-1283, 2011. PMCID: PMC3149494


Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 32:232-239, 2011.


Zerbetto M, Buck M, Meirovitch E, Polimeno A. Integrated computational approach to the analysis of NMR relaxation in proteins: application to ps-ns main chain 15N-1H and global dynamics of the Rho GTPase binding domain of plexin-B1. J Phys Chem B 115:376-388, 2011. PMCID: PMC3079214


Zhang A, Bogerd H, Villinger F, Gupta JD, Dong B, Klein EA , Hackett J Jr, Schochetman G, Cullen BR, Silverman RH. In vivo hypermutation of xenotropic murine leukemia virus-related virus DNA in peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteins. Virology 421:28-33, 2011. PMCID: PMC3208790


Zhang C, Montironi R, Maclennan GT, Lopez-Beltran A, Li Y, Tan PH, Wang M, Zhang S, Iczkowski KA, Cheng L. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate 71:1746-1751, 2011.


Zhang GF, Sadhukhan S, Tochtrop GPBrunengraber H. Metabolomics, pathway regulation, and pathway discovery. J Biol Chem 286:23631-23635, 2011. PMCID: PMC3129142


Zhang P, Zhao Y, Zhu X, Sedwick D, Zhang X, Wang Z. Cross-talk between phospho-STAT3 and PLCγ1 plays a critical role in colorectal tumorigenesis. Mol Cancer Res 9:1418-1428, 2011. PMCID: PMC3196678


Zhang T, Yong SL, Drinko JK, Popović ZB, Shryock JC, Belardinelli L, Wang QK. LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice. Int J Cardiol 147:239-245, 2011. PMCID: PMC2891203


Zhang W, McElhinny A, Nielsen A, Wang M, Miller M, Singh S, Rueger R, Rubin BP, Wang Z, Tubbs RR, Nagle RB, Roche P, Wu P, Pestic-Dragovich L. Automated Brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas. Appl Immunohistochem Mol Morphol 19:54-61, 2011.


Zhang WX, Thakur V, Lomize A, Pogozheva I, Panagabko C, Cecchini M, Baptist M, Morley S, Manor D, Atkinson J. The contribution of surface residues to membrane binding and ligand transfer by the α-tocopherol transfer protein (α-TTP). J Mol Biol 405:972-988, 2011. PMCID: PMC3038628


Zhang Y, Pfannenstiel LW, Bolesta E, Montes CL, Zhang X, Chapoval AI, Gartenhaus RB, Strome SE, Gastman BR. Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy. Clin Cancer Res 17:4975-4986, 2011. PMCID: PMC3149850


Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich JN, Hursting SD, Berger NAReizes O. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth and abrogates tumor initiating cell survival. Endocr Relat Cancer 18:491-503, 2011. PMCID: PMC3197719


Zhong B, Lama R, Smith KM, Xu Y, Su B. Design and synthesis of a biotinylated probe of COX-2 inhibitor nimesulide analog JCC76. Bioorg Med Chem Lett 21:5324-5327, 2011.


Zhong F, Harr MW, Bultynck G, Monaco G, Parys JB, De Smedt H, Rong YP, Molitoris JK, Lam M, Ryder C, Matsuyama SDistelhorst CW. Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. Blood 117:2924-2934, 2011. PMCID: PMC3062302


Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson DWillis JEMarkowitz SD, Camargo FD, Avruch J. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A 108:E1312-E1320, 2011. PMCID: PMC3241824


Zhou HL, Hinman MN, Barron VA, Geng C, Zhou G, Luo G, Siegel RE, Lou H. Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proc Natl Acad Sci U S A 108:E627-E635, 2011. PMCID: PMC3169152


Zhou L, Opalinska J, Sohal D, Yu Y, Mo Y, …et al, Saunthararajah Y, Yajnik V, McMahon C, Gore SD, Platanias LC, Levine R, Melnick A, Wickrema A, Greally JM, Verma A. Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q. J Biol Chem 286:25211-25223, 2011. PMCID: PMC3137092


Zhu J, Marchant RE. Design properties of hydrogel tissue-engineering scaffolds. Expert Rev Med Devices 8:607-626, 2011. PMCID: PMC3206299


Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, Gage FH, Verma IM. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477:179-184, 2011. PMCID: PMC3240576


Zhuang Z, Qi M, Li J, Okamoto H, Xu DS, Iyer RR, Lu J, Yang C, Weil RJ, Vortmeyer A, Lonser RR. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas. J Neurosurg 115:789-795, 2011.


Zula JA, Green HC, Ransohoff RM, Rudick RA, Stark GR, van Boxel-Dezaire AH. The role of cell type-specific responses in IFN-β therapy of multiple sclerosis. Proc Natl Acad Sci U S A 108:19689-19694, 2011. PMCID: PMC3241780


Zwiebel S, Baron E. PDT in squamous cell carcinoma of the skin. G Ital Dermatol Venereol 146:431-444, 2011.